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Abstract of the Dissertation 
 
Mechanisms Underlying Memory Deficits Following West Nile Virus Neuroinvasive 
Disease 
 
by  
Michael John Vasek 
Doctor of Philosophy in Biology and Biomedical Sciences 
Neurosciences 
Washington University in St. Louis, 2015 
Professor Robyn Klein, Chair 
 
 Neurocognitive sequelae are observed in >50% of patients who survive 
neuroinvasive infections with encephalitic arboviruses, such as the mosquito-borne West 
Nile virus (WNV)1. Early diagnosis and high survival rates from WNV neuroinvasive 
disease (WNND) (>90%) have thus led cumulatively to approximately ten thousand 
patients living with neurocognitive impairments2,3, with 1-3000 cases accruing yearly, yet 
underlying mechanisms responsible for these deficits have not been investigated. 
 Within the last 15 years, studies have begun uncover many pathways which are 
utilized both by the developing CNS as well as the immune system, including the use of 
cytokines in the regulation of progenitor cell proliferation4–6 and synaptic refinement via 
the classical complement cascade7. Under healthy conditions, an intact blood-brain-
barrier limits potential crosstalk between these domains. But amidst settings of CNS 
xi 
 
infection or damage, invocation of CNS developmental programs could be initiated by 
proinflammatory factors. With this in mind, the chapters of this thesis are centered around 
a theme of studying pathways utilized by both the immune system and the developing 
CNS and determining what the consequences are for cognition and memory during CNS 
West Nile virus infection. 
 First we have established a novel murine model of recovery from WNND in which 
intracranial inoculation of the attenuated mutant WNV-NS5-E218A8,9 leads to similar CNS 
viral loads and inflammation as peripheral inoculation of its parent strain, WNV-NY99, 
with rates of survival and cognitive dysfunction that mirror human WNND. WNV-NS5-
E218A-recovered mice exhibit impaired spatial learning without significant alterations in 
cortical and hippocampal volume or total neuron numbers, but exhibit persistently 
activated microglia. Whole transcriptome analysis of hippocampi from WNV-NS5-E218A-
recovered mice with poor spatial learning revealed increased expression of genes known 
to drive microglial effects on synaptic pruning, including the classical complement 
pathway and phagocytosis. Indeed, the classical complement cascade initiation factor, 
C1qA, was found to be produced primarily by microglia and localized to infected neurons 
and synapses during WNND. Electron and confocal microscopy revealed a loss of 
hippocampal mossy fiber synapses while synaptophysin-positive puncta and 
phagosomes containing synaptic vesicles were observed within microglia. This loss of 
mossy fiber synapses was also observed in human WNND post-mortem samples. 
Importantly, mice with fewer microglia (IL34 -/-) or mice deficient in complement (C3 -/-) 
were protected from WNV-induced synapse loss. This study provides a novel murine 
model of WNV-induced spatial memory impairment, provides evidence that viral infection 
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of adult neurons may induce complement-mediated elimination of synapses, and 
identifies a potential mechanism underlying neurocognitive impairments experienced by 
patients recovering from WNND.  
Next we report that during WNND recovery, significantly fewer new granule cell 
neurons are born within the hippocampal dentate gyrus, as revealed by BrdU-labeling. 
And although neuronal progenitor cells (NPCs) are not direct targets of WNV infection, 
their homeostatic levels of proliferation, differentiation, and migration were significantly 
altered. Using immunohistochemistry and flow cytometry coupled with in vivo BrdU 
labeling during acute WNV infection, we found NPCs within the subventricular (SVZ) and 
subgranular (SGZ) neurogenic zones generated fewer new neuroblasts, but greater 
numbers of astrocytes, an effect which slowly recovers over about 45 days. This effect 
was dependent upon Interleukin-1 receptor (IL-1R)  signaling, which we have previously 
shown to be necessary for promotion of viral clearance by T lymphocytes10.  Lastly, mice 
deficient in IL-1R were resistant to the WNV-mediated impairment in spatial learning and 
memory via the Barnes maze task at 45 days post infection, suggesting that alterations 
to neuronal progenitor cell homeostasis could also underlie long term cognitive 
consequences of WNND. 
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CHAPTER 1 – Introduction: The effects of neuroinflammation on memory and 
cognition 
 Nearly every disease of cognitive dysfunction presents with an underlying pro-
inflammatory state within the central nervous system (CNS). Proper cognitive function 
involves not only the correct assembly, maintenance, and function of existing neural 
circuits, but also the capacity to generate or enhance new circuits. It involves one to be 
able to efficiently respond to stimuli, remember past memories and associations, as well 
as make new memories and associations. Mechanistically, there is an extremely intricate 
and complex series of events underlying these tasks, of which new details are constantly 
being discovered. And as is evidenced by the number of diseases of cognitive disability 
stemming from abnormal CNS development, there are many developmental molecules 
and pathways which are critical to complex cognitive functions. In this chapter, using West 
Nile virus Neuroinvasive Disease (WNND) as an example, I will discuss the inflammatory 
response to CNS infection, cells and molecules involved in this process, and how the 
homeostatic state of the brain can be altered through invocation of several neural 
development pathways which share many molecules and receptors with the immune 
system. 
 
West Nile virus and the host immune response 
 West Nile virus is a single-stranded, mosquito-borne, arbovirus of the genus, 
flavivirus. Since WNV arrived in North America in 1999, 18,810 cases of WNV 
Neuroinvasive Disease (WNND), which include cases of meningitis, encephalitis, and 
acute flaccid paralysis, plus 22,952 non-neuroinvasive cases, mostly cases of which West 
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Nile fever (WNF), have been reported within the United States11. Symptoms of acute 
WNND include fatigue, muscle weakness, headache, fever, coma, and about 10% of 
WNND cases are fatal 12, with an estimated cost of care totaling approximately $800 
million over this period 13. Unfortunately, for the 16,000+ survivors of WNND, about half 
of patients will experience long term cognitive sequelae including, memory impairments, 
parkinsonism, word-finding difficulties, confusion, depression, and weakness12,14–17. And 
although the diagnosis of WNF is technically considered to exclude cases of CNS entry, 
some WNF patients experience symptoms for weeks to months including headaches, 
neck pain, and difficulties with concentration18, suggesting that low-level CNS infections 
may occur in WNF patients as well. To date, there have been no published studies which 
examine mechanistic causes of cognitive sequealae during WNND. 
 In studies examining post-mortem tissue from acute WNND patients, WNV has 
been found within neurons of many different regions of the CNS including the frontal 
cortex, hippocampus, thalamus, basal ganglia, brainstem, cerebellum, and spinal cord19. 
Fortunately, a well-established murine model of acute WNND exists and many insights 
into WNV pathogenesis and the host immune response against it have been gained over 
the last 15 years. WNV primarily infects neurons within the CNS20 and can induce their 
apoptosis via Caspase-321. 
 There are several steps between the mosquito bite and CNS invasion by WNV. 
And though the blood-brain-barrier is an important mechanism in CNS pathogen defense 
and is able to exclude many pathogens from entry, WNV as well as several other 
members of the flavivirus genus, including Japanese Encephalitis virus and St. Louis 
encephalitis virus, are known for their ability cause neuroinvasive disease. First, 
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mosquito-borne WNV enters the dermis and infects local Langerhans dendritic cells, 
which then traffic to the lymph nodes22. At this stage, the initiation of a successful innate 
immune response, including upregulation of type I and II interferons, likely prevents 
further viral spread in asymptomatic or mild WNF cases23,24. But if WNV is not controlled 
within the periphery, viremia develops, followed by potential invasion into the CNS24. And 
although the exact mechanism by which WNV enters the CNS is not known, especially in 
human pathogenesis, several possible theories have been discussed. In response to 
WNV and other neurotropic viruses, peripheral-derived cytokines such as Tumor Necrosis 
Factor-α (TNFα), Interferon-γ, and Interleukin-1β may act to temporarily permeabilize the 
blood brain barrier, facilitating viral entry25,26. Another hypothesis is that WNV gains CNS 
entry through a “trojan horse” method27, initially brought in by an infected leukocyte, 
similar to the mechanism of HIV CNS invasion. Finally, WNV has been observed to travel 
along peripheral nerve axons and undergo retrograde trans-neuronal trafficking in a 
sciatic nerve infection model, suggesting that spread from peripheral nerves into the 
spinal cord may be another possible route of CNS entry28,29. 
 
The complement system of pathogen defense 
 The complement system is a well-studied cascade of proteins involved in 
recognizing and facilitating the opsinization or lysis of foreign material as well as apoptotic 
cellular debris30. This process from recognition to opsinization or lysis can occur within 
seconds to minutes of an invading pathogen entering the blood and is a very important 
component of early immune defense. There are three potential initiating pathways, the 
classical, lectin, and alternative pathways, which all converge and lead to either 
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opsinization or formation of the membrane attack complex, acting to lyse the cell or 
pathogen. The classical pathway is initiated by the factor C1q binding to aggregated 
IgG/IgM antibodies or other moieties such as nucleic acids or amyloids, setting off a series 
of zymogen activations via recruitment and cleavages of additional factors (C1r, C1s, C4, 
C2, and C3)30. The Lectin pathway is initiated by mannan-binding lectin or ficolins, which 
recognize carbohydrates and polysaccharides on pathogen surfaces31. The alternative 
pathway relies on the spontaneous hydrolysis and activation of complement, which due 
to a short half-life, would only continue amplification in the absence of endogenous 
regulators and inhibitors, such as decay accelerating factor and membrane cofactor 
protein (MCP)32. The alternative pathway can also act as an amplification loop for 
complement activation derived from the classical and lectin pathways. All three pathways 
lead to either the eventual cleavage of C3 into iC3b, which causes the particles or cells 
to be recognized and engulfed by phagocytes such as macrophages and microglia, or 
formation of the membrane attack complex via sequential activations of C5, C6, C7, C8, 
and C9, resulting in membrane lysis33. 
 All three activation arms of the complement pathway can independently contribute 
to anti-WNV host defense. Mice deficient in components of either the alternative, 
classical, or lectin pathways show increased viral loads and enhanced mortality to WNV 
in a peripheral infection model34. Additionally, mice deficient in either the lectin or classical 
pathways produced lower levels of anti-WNV antibodies and had less reactive T cells34,35. 
Interestingly, WNV and related flaviviruses, antagonize complement C4 activity through 
binding of the virus’ non-structural protein, NS136, further suggesting a key antiviral 
defense role for the complement pathway. 
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Leukocytes and cytokines in anti-WNV defense 
 Following WNV neuro-invasion, leukocytes have been shown to play important 
roles in aiding viral clearance. CD8+ T lymphocytes, especially, are indispensable in 
mediating viral clearance37. CD4+ T lymphocytes38 and B cells39 are also important for 
WNV clearance. Several cytokines including CXCL1040, Interleukin-1β10, Tumor Necrosis 
Factor α (TNFα)41, CXCL1242,43, and CCL3-CCL544 play important roles in helping to 
recruit T cells, macrophages, and other leukocytes into the CNS and across the brain 
endothelium into the infected brain parenchyma. 
 
Microglia as immune cells of the CNS 
 Microglia, as the resident phagocytes of the brain, are frequently in close proximity 
to and involved during episodes of CNS damage or infection. They have been shown to 
phagocytize viruses, bacteria, and apoptotic cellular debris in these settings45. 
Furthermore, they are potent producers of many antimicrobial molecules, such as nitric 
oxide, as well as cytokines and chemokines such as Interleukin 1β, Interleukin 6, Tumor 
necrosis factor alpha (TNFα), and CXCL1046. While these microglial-derived oxidative 
molecules and cytokines may be instrumental in microbial defense, several studies have 
pointed to neurotoxic roles for microglia, especially in neurodegenerative conditions such 
as Alzheimer’s disease47. Furthermore, during Japanese Encephalitis Virus, over-
activation of microglia could contribute to the observed neurotoxicity in the murine 
model48. 
 
6 
 
Neural development 
The (CNS) does not instantly attain the ability to perform complex cognitive tasks 
from the moment that the neural tube takes shape, but rather must follow an intricate and 
prolonged series of developmental events. During neurulation, gradients of bone 
morphogenic proteins, Wnts, transforming growth factor beta (TGFβ), and Homeobox 
domain genes help to establish asymmetry and the basis for CNS patterning49. This 
allows for formation of ventricles and the ventricular zone immediately adjacent, where 
multipotent neural stem cells (radial glia) give rise to transit-amplifying progenitors, which 
in turn proliferate further in order to generate the many millions of neuroblasts, many of 
which will develop into mature neurons. 
 
Axon guidance, synaptic connections, and synaptic refinement 
 Following and during developmental neurogenesis, neurons from all the different 
regions of the CNS begin to establish synapses with target neurons, forming circuits 
which will eventually serve as the basis for cognition. During this stage and for the rest of 
life, new neuronal connections can be made, unnecessary connections can be removed, 
and existing connections can be strengthened or weakened50. 
Proteins of the MHC class I  (MHCI) complex, including MHCI, TAP and Beta 2 
microglobulin, expressed by nearly all cells, are key to the immune system’s ability to 
distinguish self from non-self51,52. Peptide fragments of proteins from the cell’s lysosomal 
pathway are presented by the MHC complex on the cell surface for potential recognition 
by T lymphocytes. Thus, when a cell is infected with a pathogen, peptide fragments of 
that pathogen will be able to be presented to T cells, priming the immune system to invoke 
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a response. Interestingly, within the last 15 years it was discovered that neurons express 
high levels of MHCI, usually only upregulated during infection53, during the CNS 
developmental stages of axon guidance and synapse formation/refinement54. It was later 
discovered that neurons also express an MHCI receptor, Paired Immunoglobulin-like 
Receptor B (PirB), as well as the CD3ζ chain subunit of the T cell receptor, and that 
expression of neuronal MHCI and its receptors was required for proper axon targeting, 
synapse formation, and ocular dominance plasticity within the mammalian visual 
system55–57. It is interesting that T lymphocytes and neurons, two cell types which often 
undergo long distance migrations and then must identify highly specific targets, have both 
adapted versions of the MHCI system for target recognition. 
Earlier in this chapter, I discussed the critical role of the Complement system in 
innate immune pathogen defense, which has been discovered over 100 years ago58. 
Recently in 2007, components of the classical complement cascade have been shown to 
be highly expressed in the period of CNS development during which excess synapses 
are pruned to promote the maintenance of efficient and synchronous neuronal circuits7. 
Deficiency in the classical complement pathway resulted in mice which were not able to 
properly refine their visual system into eye-specific layers. Later, it was discovered that 
microglia, through expression of the complement receptor 3 (CR3) facilitate this synaptic 
pruning through recognition of C3 and iC3b deposition on neuronal synapses, and that 
this process is regulated by neuronal activity59. Though the expression of CNS classical 
complement components is reduced following the period of synaptic pruning, there is 
evidence that the system can be restimulated during adulthood in several neurologic 
disease states including Alzheimer’s Disease60,61 and Multiple Sclerosis62. The intriguing 
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scenario where the classical complement cascade is activated during adult CNS 
neurotropic WNV infection will be discussed in detail in Chapter 2 of this thesis. 
Several other molecules are utilized during CNS development for axon guidance 
and synapse refinement which are either expressed by the immune system or are related 
to immune genes. Neuronal pentraxins, which are highly related to C reactive protein and 
Serum amyloid P component protein, two pattern recognition receptors of the immune 
system, have also been shown to play a role in synaptic plasticity and refinement63. 
Finally, the chemokine CXCL12 and its two receptors, CXCR4 and CXCR7 regulate both 
the trafficking of leukocytes across endothelial barriers64,65 as well as the proliferation5 
and migration of neuronal progenitors during development66,67. 
 
Adult neurogenesis 
 In mammals, the generation of new neurons completely halts in most brain regions 
within a few weeks of life, but two brain regions continually generate new neurons 
throughout adulthood: the dentate gyrus (DG) of the hippocampus and the subventricular 
zone (SVZ), whose progenitors give rise to neuroblasts which migrate into the olfactory 
bulb, a vestigial organ in humans68. Within the DG, adult neural stem cells can give rise 
to progenitors which will eventually generate either astrocytes or neurons69, and within 
the SVZ neural stem cells can additionally give rise to oligodendrocyte precursors70. 
Within both zones, along the neuronal lineage, rapidly dividing transit-amplifying 
progenitors (also known as “intermediate progenitors”) give rise to neuroblasts, which 
begin to migrate to their target areas. Once neuroblasts arrive at their correct layers, the 
olfactory bulb for SVZ-derived neuroblasts, and the granule cell layer for DG-derived 
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neuroblasts, they either gradually integrate into the neuronal circuit or become 
apoptotic71. And although the extent of the functional contribution of adult-born neurons 
is not precisely known within this relatively young field, it is known that mice whose adult 
neurogenesis is severely impacted, for example via radiation, suffer impairments in 
certain spatial learning and memory tasks72, as well as fear-associated memory tasks73. 
Furthermore, tasks such as environmental enrichment and voluntary running, which boost 
cognitive performance also increase rates of adult neurogenesis71. Because newborn 
neurons display a period of enhanced excitability as they integrate into the neuronal 
network, it is speculated that this could add an additional layer of contextual memory 
enhancement, especially within the DG74.  
 Of interest, neural stem and progenitor cells seem to be particularly affected by 
cytokines in settings of damage or infection (reviewed in 75). During CNS development, 
such conditions can have drastic consequences, but also during adulthood, within the two 
regions of adult neurogenesis (only the hippocampus in humans), changes to progenitor 
cell proliferation, migratory patterns, and cell-fate differentiation could affect cognition. 
How SVZ and DG adult neurogenesis are affected during the immediate acute phase as 
well as the recovery phase following West Nile neuroinvasive infection will be the focus 
of chapter 3 of this thesis.  
 
Microglia during development and in healthy conditions 
 Although roles for microglia within tumor models, CNS damage, and infections 
have been documented for over a century76,77, only within the last 5-10 years have we 
begun to understand microglia’s function in the healthy brain. Microglia arise from early 
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myeloid progenitors during the yolk-sac stage of development, which migrate into the 
CNS before a blood-brain-barrier has been established and represent a distinct lineage 
from circulating monocytes78. Thus, they are present during the very early stages of CNS 
development and indeed play critical roles during this time. Microglia act as important 
sources of growth factors such as basic fibroblast growth factor for neural progenitors and 
promoting survival of neurons79. Microglia also phagocytize ventricular zone neuronal 
progenitors during the end stages of embryonic cortical neurogenesis80, presumably to 
help limit the genesis of new precursors and neurons once enough neurons have been 
generated. Following neurogenesis, microglia also act to induce apoptosis of excess 
neurons81,82. Within the hippocampus, this process has been shown to require Dap12 and 
CD11b, which along with CD18, comprises Complement Receptor 383. Interestingly, 
mutations in either Dap12 or TREM2, two proteins which are only expressed within the 
CNS by microglia, in humans can cause a loss of function inherited dementia termed 
nasu-hakola disease84. Of interest, both Dap12 and TREM2 are involved in the regulation 
of phagocytosis by microglia and Dap12 can affect synaptic function85. These studies 
suggest that in order for proper cognitive functioning to occur and be maintained, the 
phagocytic activity of microglia must remain intact. 
 As previously discussed, microglia mediate the pruning of synapses via 
complement during normal CNS development59. This process has been shown to be 
necessary for proper brain development and function86. Furthermore, depletion of 
microglia during development using diphtheria toxin in a CX3CR1-DTR murine model 
causes impairments in multiple learning tasks87. Microglia are now known to contribute to 
synapse maintenance during healthy adulthood and have been shown to constantly 
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monitor and contact nearby synapses, in addition to their roles during development88. 
Aiding in this process, microglia express the receptor, CX3CR1, which recognizes the 
ligand, CX3CL1, which is expressed by neurons45. Indeed, murine deficiency in CX3CR1 
lead to impairments in spatial learning and synaptic plasticity89.  
It should not be surprising that microglia, which are responsible both for the 
maintenance and refinement of synapses under healthy conditions, as well as 
antimicrobial functions such as cytokine release and phagocytosis during CNS 
inflammatory conditions, are deeply entwined in studies on the effect of 
neuroinflammation on cognition. This is especially of interest when groups of molecules 
like the Complement proteins mediate the opsinization and phagocytosis of both 
synapses and pathogens, during normal CNS development and inflammatory conditions, 
respectively. This dual role of microglia will be investigated and discussed in chapter 2. 
 
  
12 
 
CHAPTER 2 - A complement-microglial axis is required for synapse elimination 
during virus-induced memory impairment 
 
This chapter is derived from the following manuscript 
 
A complement-microglial axis is required for synapse elimination during virus-
induced memory impairment 
 
Michael J. Vasek1, Charise Garber1, Denise Dorsey1, Tony Sun1, Bryan Bollman1, 
Douglas Durrant1, Jinsheng Yu2, Carlos Perez-Torres3, Arnaud Frouin4, Daniel Wilton4, 
Xiaoping Jiang5, Steven Mennerick5, John Robinson6, Kenneth L. Tyler8, Joel Garbow3, 
Robert E. Schmidt7, Beth Stevens5, and Robyn S. Klein1,7,9 
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Department of 4Neurology, F.M. Kirby Neurobiology Center, Boston Children's Hospital, 
Harvard Medical School, Boston, MA 02115 
Department of 6Integrative Neuroscience, Stonybrook University, Stony Brook, NY 
11794 
Department of 8Neurology, University of Colorado School of Medicine, Aurora, CO 
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Abstract 
Neurocognitive sequelae are observed in >50% of patients who survive neuroinvasive 
infections with encephalitic arboviruses, such as the mosquito-borne West Nile virus 
(WNV)1. Early diagnosis and high survival rates from WNV neuroinvasive disease 
(WNND) (>90%) have thus led cumulatively to approximately ten thousand patients living 
with neurocognitive impairments2,3, with 1-3000 cases accruing yearly, yet underlying 
mechanisms responsible for these deficits have not been investigated. Here, we 
established a novel murine model of recovery from WNND in which intracranial 
inoculation of the attenuated mutant WNV-NS5-E218A8,9 leads to similar CNS viral loads 
and inflammation as peripheral inoculation of its parent strain, WNV-NY99, with rates of 
survival and cognitive dysfunction that mirror human WNND. WNV-NS5-E218A-
recovered mice exhibit impaired spatial learning without significant alterations in cortical 
and hippocampal volume or total neuron numbers, but exhibit persistently activated 
microglia. Whole transcriptome analysis of hippocampi from WNV-NS5-E218A-recovered 
mice with poor spatial learning revealed increased expression of genes known to drive 
microglial effects on synaptic pruning, including the classical complement pathway and 
phagocytosis. Indeed, the classical complement cascade initiation factor, C1qA, was 
found to be produced primarily by microglia and localized to infected neurons and 
synapses during WNND. Electron and confocal microscopy revealed a loss of 
hippocampal mossy fiber synapses while synaptophysin-positive puncta and 
phagosomes containing synaptic vesicles were observed within microglia. This loss of 
mossy fiber synapses was also observed in human WNND post-mortem samples. 
Importantly, mice with fewer microglia (IL34 -/-) or mice deficient in complement (C3 -/-) 
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were protected from WNV-induced synapse loss. Our study provides a novel murine 
model of WNV-induced spatial memory impairment, provides evidence that viral infection 
of adult neurons may induce complement-mediated elimination of synapses, and 
identifies a potential mechanism underlying neurocognitive impairments experienced by 
patients recovering from WNND.  
 
Introduction  
In 2003, WNV produced the largest encephalitic arbovirus epidemic within the USA 
on record (9,862 cases) and continually resurges every year2,90. Since its emergence in 
North America in 1999, rodent models have yielded insights into the neuropathogenesis 
of WNV, demonstrating critical roles for innate and adaptive immune responses in 
controlling peripheral infection and neuroinvasion24. WNV is capable of infecting neurons 
within several CNS regions including the basal ganglia, brain stem, cerebellum, cortex, 
hippocampus, and spinal cord19,23,40,91,92. In human post-mortem WNND patient samples 
and in rodent models with low survival rates (<50%), significant neuronal loss, leukocyte 
infiltration, and microglial activation occur within infected brain regions10,21,43,93, however, 
the extent and location of viral burden and neuronal loss may be significantly different 
within the >90% of patients who survive the acute phase of WNND. Moderate viral 
burdens, variations in the locations of infection, and differential host-pathogen interactions 
could explain the diverse array of cognitive sequelae experienced by WNND survivors, 
which includes memory impairment, parkinsonism, confusion, and ataxia12,94. Studies in 
humans and rodents indicate that cortical structures such as the hippocampus are among 
the highly targeted areas of infection19, and patient survivors of both WNND and West 
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Nile Fever (WNF), a flu-like illness that occurs in 20% of cases95, often suffer from 
impairments to visuospatial processing and memory96,97. The hippocampus is essential 
for spatial and contextual memory formation via a trisynaptic circuit between the 
entorhinal cortex and the dentate gyrus, CA3, and CA1 regions of the hippocampal 
formation98. Damage to hippocampal neurons, their synaptic connections, or alterations 
in expression of critical gene pathways could restrict proper spatial memory formation or 
memory recall. 
 Microglia, the only resident myeloid cell type within the CNS parenchyma, exhibit 
critical roles in immune defense, antigen presentation, and as phagocytes within the 
virally infected CNS99,100. Recent studies in mice have additionally highlighted important 
roles for microglia in the development and maintenance of proper neuronal synapses59,88. 
Mice deficient in CX3CR1 – CX3CL1 signaling, which are expressed by microglia and 
neurons within the CNS, respectively, exhibit impaired developmental synaptic 
pruning101, impaired spatial learning and memory89, and reduced hippocampal long term 
potentiation (LTP)89. Recently, studies have shown that the proteins C1q and C3, 
members of the classical complement cascade which assist in the opsonization of 
pathogens and apoptotic debris, are necessary for the pruning of weak retinothalamic 
and cortical synapses during murine CNS development7,102. Microglia recognize and 
phagocytize synaptic elements through their expression of complement receptor CR3, 
which recognizes C359. The classical complement system is activated and contributes to 
control of WNV dissemination following peripheral WNV infection34, but whether 
complement is induced within the brain during WNND has not been investigated. It is 
unknown how microglia manage their dual roles in pathogen recognition/clearance and 
16 
 
synaptic modeling and how complex brain processes such as learning and memory may 
be affected as a result of viral infection of the CNS. 
 
Results 
 The neuropathogenesis of cognitive impairments in patients recovering from 
WNND or WNF are unknown, in large part due to lack of good murine recovery models.  
Current murine models that utilize WNV-99 (NY isolate 1999) yield either 100% death 
following i.c. WNV infection41 or 10-70% survival and variable CNS viral burdens following 
peripheral routes of infection, depending on the age of the mice103,104. While hamster 
models show better survival and are therefore more amenable to spatial learning tasks, 
they lack the attractive genetic approaches available for murine models105. To circumvent 
this, we utilized a strain of WNV with a point mutation in nonstructural protein 5 (WNV-
NS5-E218A), which lacks functional 2′-O methyltransferase, an enzyme which generates 
a 5’ cap on viral RNA to evade type I interferon-mediated restriction of viral translation8,106 
to develop a novel model of recovery from WNND for evaluation of spatial learning. While 
this mutation does not prevent replication in permissive cells, we previously reported that 
90% of 8 week-old mice survive an i.c. inoculation (104 pfu) (Fig. 2.S1a), resulting in 
uniform viral brain burdens that peak between 6-8 days post infection (dpi)9, with near 
complete viral clearance from the brain at 15 dpi (Fig. 2.S1b-c), although positive sense 
(non-replicating strand) viral RNA may be detected by quantitative PCR in low levels (5-
10 copies per 10000 copies of GapDH) for weeks as previously described for WNV-
NY00107, RNA from the replicating, negative sense strand, of WNV was completely absent 
at 25 and 52 days post-infection, providing evidence against any persistent CNS WNV 
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infection in our model (Fig. 2.S2a). Mice i.c. infected with WNV-NS5-E218A develop a 
robust CNS inflammatory response within 7 dpi, with numbers of infiltrating leukocytes, 
lymphocytes, macrophages and microglia not significantly different from those observed 
during i.c. infection of WNV-NY99 (Fig. 2.S1d), consistent with prior data demonstrating 
early reversion of WNV-NS5-E218A to wild-type virus within the CNS9. Acute WNV-NS5-
E218A i.c. infection resulted in low, but measurable numbers of apoptotic neurons (0.5 – 
1.5%) at 7 dpi (Fig. 2.S1e) numbers comparable to that observed in 8 week-old mice after 
f.p. infection with WNV-NY9921. These data indicate that WNV-NS5-E218A may be used 
as a model to examine behavioral, cellular, and molecular mechanisms of CNS recovery 
from WNND. 
 To determine whether WNV-NS5-E218A-recovered mice exhibit neurocognitive 
disturbances, 8 week-old, infected mice were permitted to recover for over a month p.i. 
(45 dpi), followed by assessment of their ability to spatially locate and remember the 
location of a target hole over the course of 5 consecutive days of testing on the Barnes 
maze behavioral task108. On average, mice recovering from WNV encephalitis exhibit a 
significantly slower learning curve than mock-infected controls, committing more errors 
(Fig. 2.1a; p = 0.0008 by two-way repeated measures ANOVA) and requiring significantly 
more time (Fig. 2.1b; p = 0.016 by two-way repeated measures ANOVA) before locating 
the target hole on days 2-5 of testing (data not shown). WNV recovered animals 
eventually learn the task, although they continue to make more errors than mock-infected 
controls, even after 5 days of learning. Of note, recovered animals do not exhibit any 
impairments in activity or exploratory anxiety as assessed through number of lines 
crossed or center crosses, respectively, in an open field behavioral assessment at 45 
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days p.i. (Fig. 2.1c-d), indicating that impairments in solving the Barnes maze are specific 
to spatial learning deficits. 
Prior studies reported that WNV may trigger caspase-3-dependent apoptosis in 
infected neurons of animals that succumb to WNND21. Quantitative 
immunohistochemistry did not detect ongoing apoptosis (Fig. 2.S2b) or significant loss of 
NeuN+ neurons within the dentate gyrus, hippocampal CA1, hippocampal CA3, 
entorhinal/perirhinal cortex, and visual cortex, regions associated with learning and 
memory (Fig. 2.S2c). Similarly, volumetric brain analysis at 52 dpi, as assessed by MRI, 
revealed no difference in hippocampal or total brain volume in mock- versus WNV-NS5-
E218A-recovered animals (Fig. 2.S2d). While immunofluorescent studies revealed an 
increase in reactive astrocytes within the cortex in WNV-NS5-E218A- versus mock-
infected animals (data not shown), this was not observed within the hippocampus (Fig. 
2.S3a). However, microglial nodules within several brain regions, including the 
hippocampus, were detected via standard histology (arrowhead in Fig. 2.S3b) and WNV-
recovered animals exhibited significantly increased levels of the microglial and 
macrophage activation markers, IBA1 (Fig. 2.1e) at 7, 25, and 52 dpi, and CD68 (Fig. 
2.1f-g) at 7 dpi. Colocalization of CD68 staining in CX3CR1-GFP heterozygous mice 
shows CD68 upregulation both on microglia (CX3CR1-GFP-positive; white arrowheads) 
and on infiltrating macrophages (red arrowheads) at 7 dpi with WNV-NS5-E218A (Fig. 
2.1f). 
 Microglia have been shown to exhibit distinct transcriptomic signatures, expressing 
a unique cluster of transcripts that encode proteins involved in sensing endogenous 
ligands and microbes (microglial sensome)109. To identify molecular mechanisms that 
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underlie memory dysfunction in our WNV-recovered animals, we performed whole-
transcriptome microarray to compare RNA transcripts differentially expressed in mock- 
versus WNV-NS5-E218A-infected mice at 25 dpi, a time-point at which infectious virus is 
cleared and animals display spatial learning defects. Profiling total RNA from the 
hippocampi of mock- versus WNV-NS5-E218A-infected mice revealed differential 
expression of 1364 transcripts (p<0.05, FC > 1.5) between mock versus WNV-NS5-
E218A-recovered animals (Table 2.S1). Pathway analyses of these genes identified 
genetic signatures associated with a variety of neural correlates of spatial memory, 
including the generation and maintenance of synapses and neurogenesis, especially 
those involving activation of innate immune responses and the microglial sensome (Table 
2.S2). In the latter category, we identified genes associated with microglial-mediated 
phagocytosis (CX3CR1, Dap12, FcγR1G, FcγR2, Rac2, WAS) and the classical 
complement pathway (C1qA, C2, C3, C4b, Serping1) (Fig. 2.2a), which were validated 
via quantitative (Q)PCR (Fig. 2.2b).  
To identify gene expression signatures specifically associated with spatial learning 
defects, we took advantage of individual variability in spatial learning performance 
displayed by WNV-NS5-E218A-recovered animals, categorizing WNV-NS5-E218A-
infected mice into those that perform similar to mock-infected animals (good learners – 
fewer than 8 errors) and those that exhibit severe learning deficits (poor learners – greater 
than 10 errors), based on Barnes maze results on the second day of testing (Fig. 2.2c-
e). Categorization of mice into good versus poor learners revealed 747 genes that were 
significantly increased in the WNV-poor learners, 45 genes altered in WNV-good learners, 
and 572 genes altered in both groups compared to mock-infected littermates (Fig. 2.2f) 
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(Table 2.S3). Prior studies indicate that intraparenchymal lymphocytes, especially CD8+ 
T cells, persist in the CNS after recovery from WNND110. Consistent with this, many of 
the genes identified encoded proteins associated with innate and adaptive immunity 
including interferon-stimulated genes (ISGs), cytokines, chemokines and many 
immunoglobulin domains. Because lymphocytes have been shown to drive microglial 
activation111–113, we examined microglial sensome and synapse genes in additional 
cohorts of WNV-NS5-E218A-recovered good and poor learners following Barnes maze 
screening.  QPCR evaluation of hippocampi derived from WNV-NS5-E218A-recovered 
increased levels of C1qA and decreased levels of Dlg2 and Grm5 are especially 
associated with poor spatial learning (Fig. 2.2g). Prior studies have shown that Dap12, 
114–117. 
Serping1 and CRRY, inhibitors of the classical complement cascade, are known to be 
expressed in the setting of complement-mediated tissue loss in mice118,119. C1qA has 
been shown to be involved in synaptic pruning during development7 and in certain disease 
models including multiples sclerosis62 and spinal cord injury120. Dlg2 acts as a synaptic 
scaffolding protein involved in complex learning121, whereas Grm5 and Grin1 are 
components of metabotropic and ionotropic glutamate receptors, respectively – each 
shown to contribute to hippocampal plasticity122,123 and have been previously found to be 
downregulated in mouse brain during acute phases of WNV, Japanese Encephalitis virus, 
and Reovirus infections124. KEGG pathway analyses of genes differentially altered (fold 
change > 1.5 and p < 0.05) between WNV-good vs. WNV-poor mice reveal cytokine 
signaling, calcium signaling, and B-cell receptor signaling among the top pathways found 
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to be upregulated in WNV-poor mice (Table S4), whereas downregulated pathways 
included LTP, axon guidance, and wnt signaling (Table S5). As all WNV-infected mice in 
our study exhibit inflammation during viral clearance, which is equivalent in good and poor 
learners (Fig. 2.2h), these differentially expressed genes suggest that poor spatial 
learners exhibit alterations in pathways specifically tied to cognitive function. 
 Given the alterations in genes relating to synaptic function we evaluated synapse 
numbers within the hippocampus of WNV-NS5-E218A-infected mice. Quantitation of 
synaptophysin-positive puncta within the stratum lucidum of the hippocampal CA3 (mossy 
fiber synapses) detected a 25% reduction in presynaptic terminals during the peak of viral 
brain titers in WNV-NS5-E218A-infected animals compared to mock-infected, age and 
sex-matched controls (Fig. 2.3a). Importantly, mice i.c. or f.p. inoculated with wild-type 
WNV (WNV-NY99) showed similar reductions in synapse numbers to the WNV-NS5-
E218A mutant strain during peak infection (Fig. 2.4a). Of interest, synapses from mice 
with fewer and less proliferative microglia (IL34 -/-)125, however, were not significantly 
altered during WNV-NS5-E218A acute infection (Fig. 2.3a). In wild type animals, 
evidence of hippocampal synapse loss continued to be detectable out to 25 days post-
infection where WNV-NS5-E218A-recovered mice with severe spatial learning 
impairments (WNV-poor) had significantly fewer VGlut1-positive synapses than their 
WNV-NS5-E218A-infected littermates with intact spatial learning (WNV-good), which had 
fewer synapses than mock-infected controls (Fig. 2.3b). 
  Colocalization studies also observe synaptophysin-positive puncta within GFP+ 
cells of WNV-NS5-E218A-infected CX3CR1GFP heterozygous mice (Fig. 2.3c), best 
observed via 3-dimensional reconstruction using confocal microscopy (data not shown), 
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demonstrating that resident microglia are pruning synapses. Immunohistochemistry and 
quantification of colocalization between IBA1 and synaptophysin reveal significantly 
increased numbers of microglia-engulfed presynaptic terminals in the hippocampal CA3 
from WNV-NS5-E218A-infected mice at days 7 and 25 post-infection (Fig. 2.3d). By 
contrast, WNV-NS5-E218A did not induce any increase in astrocyte colocalization with 
synapses (Fig 2.S4b). Electron microscopy of the CA3 and molecular layer of the 
hippocampus (Fig 2.3e) during acute WNND confirm this synapse loss and identify 
microglia that are greatly enriched in phagosomes, including phagosomes containing 
40nm synaptic vesicles (red arrowheads) and those observed extending processes that 
surround synapses (Fig. 2.3ei), which is rarely seen in mock-infected controls. Moreover, 
quantitation of synaptophysin-positive puncta within acute post-mortem WNND patient 
specimens showed significantly reduced hippocampal CA3 synapse numbers compared 
to age-matched patient controls (median age for each cohort = 62.6 years, n = 5 WNV 
cases and 8 control cases) (Table 2.6) (Fig 2.3e). Of note, synapse numbers within the 
CA3 of WNND patients under 60 years old were comparable to levels observed from 
control patients 20-30 years older (Fig 2.3e). In 3 out of 5 WNV cases, West Nile virus 
antigen could be detected within the hippocampal CA2/CA3 region, but West Nile antigen 
was mostly absent from other neighboring regions (Dentate Gyrus: 0/5, CA1: 0/5 cases, 
Entorhinal Cortex: 1/5 cases) (Table S6 and Fig 2.S5a). Quantification of synaptophysin-
positive area within the hippocampal CA1 and entorhinal cortex in the human patient 
samples displayed synapse reduction that was not significant (p = 0.1), (Fig. 2.S5 b, c). 
          As macrophage-mediated phagocytosis is often accompanied by antibody and 
complement deposition in the periphery in order to enhance opsinization of dying cells 
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and pathogens, we next sought out to determine if either or both components of this 
pathway were necessary for WNV-mediated synaptic pruning.  Double-label 
immunohistochemistry for endogenous mouse IgG and the presynaptic marker, VGlut1, 
revealed no differences in the amount of endogenous mouse IgG coating VGlut1-positive 
hippocampal CA3 synapses at both 7 and 25 dpi following WNV-NS5-E218A compared 
to mock-infected controls (Fig. 2.S6a). Furthermore, WNV-NS5-E218A-infected B cell-
deficient mice (µMT-/-) exhibited similar levels of synapse loss within the hippocampus as 
infected wild-type mice (data not shown), confirming that B cells and antibodies are not 
necessary for WNV-mediated synapse reduction. 
 Based on our microarray results identifying WNV-induced alterations in the 
classical complement cascade and prior studies delineating a role for complement in 
microglial synaptic pruning during development7,59, we next determined if complement 
might mediate the microglial phagocytosis of synapses during WNV infection. 
Hippocampal upregulation of the initiating factor of the classical complement cascade, 
C1qA, was detected by quantitative RT-PCR at days 7, 25, and 52 p.i. compared to mock-
infected age-matched controls (Fig 2.4a). To identify cellular sources of C1qA, we 
performed in situ hybridization using RNA probes for C1qA together with antibodies to 
neuron specific enolase (NSE) and IBA1. IBA1-positive cells were the main producers of 
hippocampal C1qA mRNA, both in mock-infected and WNV-NS5-E218A-infected mice, 
which showed increased levels (Fig 2.4b). Within IBA1+ cells, C1qA mRNA expression 
can commonly be seen within processes adjacent to or surrounding neurons (insets: 
arrowhead in Fig 2.4b). Double-label immunohistochemistry confirmed co-localization of 
C1qA with IBA1 (Fig 2.4c, white arrowheads), however, as C1qA is a secreted protein, 
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much of the C1qA staining appears in extracellular spaces surrounding IBA1+ cells. 
Within WNV-NS5-E218A-infected mice at 7dpi, C1qA can be found within the 
hippocampal CA3 colocalized within WNV antigen-positive infected neurons (Fig 2.4d) 
and with VGlut1-positive presynaptic terminals in greater levels than mock-infected 
controls (Fig 2.4e-f). To determine if complement was necessary for WNV-mediated 
hippocampal synapse pruning, we examined synapse loss at 7 days post-infection in 
mock- versus WNV-NS5-E218A-infected C3-/- littermate mice and found equivalent 
numbers of synaptophysin-positive puncta in both groups (Fig 2.4g), indicating that WNV-
mediated synapse elimination requires complement C3, the converging point of the 
complement pathways.  
 
Discussion 
 Multiple studies, better diagnoses, and greater numbers of survivors of WNND 
over the last 10 years have begun to highlight the prevalence of cognitive impairments in 
this population, however there is little cellular and molecular understanding of these 
impairments14,15,97,126. Using a novel murine model to study memory impairments during 
recovery from WNND, we show that mice exhibit spatial learning and memory deficits 
during recovery and robust microglial activation during the acute phase that persists for 
nearly two months post-WNV infection. Using electron and confocal microscopy, we 
demonstrate that these activated microglia phagocytize synapses during the peak of 
WNV infection, leading to a significant loss of synapses in the hippocampus and 
entorhinal cortex. Using whole transcriptome array approaches we identified genes and 
pathways associated with poor spatial learning, including molecules involved in 
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microglial- and complement-mediated phagocytosis of synapses. Consistent with these 
data, we observed upregulation of complement protein C1q within neurons and microglia 
and showed that CA3 synapse elimination is abolished in mice deficient in either microglia 
or complement C3. Moreover, we detected significantly reduced numbers of hippocampal 
CA3 synapses in post-mortem specimens from human cases of WNV encephalitis 
compared with age- and sex-matched controls, highlighting the relevancy of our murine 
model for human infections with WNV. Our study is the first to show synapse elimination 
as a pathological feature of WNV encephalitis and to delineate mechanisms that underlie 
this elimination.  
The ability of WNV to infect and kill neurons has been well-described in human 
cases of WNV encephalitis127 and in rodents lethally infected with WNV-NY99128, 
however, infection with attenuated WNV-NS5-E218A induces spatial learning and 
memory deficits, despite lack of neuron loss during peak infection (Fig. 2.S1e) or at one 
month post-clearance (Fig 2.S2b). These data suggest that significant neuron loss is not 
required for deficits in cognitive function. Consistent with this, WNF patients also report 
cognitive impairments for months following infection18, suggesting that low levels of CNS 
viral burden that do not lead to overt encephalitis may be capable of affecting cognition 
through disruptions in the network of synapses in the absence of neuron loss.  
 Complement, which has a well-described role in coating apoptotic cells and cellular 
debris for opsonization, has recently been implicated in synapse elimination by 
microglia7,59. Many pathogens and pathogen-associated molecular patterns have been 
shown to induce complement activation within the CNS, including WNV35, HIV129, amyloid 
plaques130, and prion proteins131. CNS cell types, including neurons, astrocytes, and 
26 
 
microglia can express complement components, including C1q130. Persistence of viral 
nucleic acid or intraparenchymal migration of macrophages that harbor viral antigen may 
promote microglial and complement activation via pathogen recognition132–136. Microglial-
mediated synapse modulation has been observed in mice both during development7 as 
well as in adult animal models of Alzheimer’s Disease and Parkinson’s disease, both 
shown to be dependent on Complement C3 and its receptor, CR3137,138. Our model of 
WNV-mediated synaptic pruning is similar in this regard to these cases of synaptic 
pruning, in that it also requires complement C3. Although synapses are labeled by 
complement C1qA and lost during WNV infection, it is unknown whether these synapses 
are connected to healthy neurons, infected neurons, or a mixture of the two. In situ 
hybridization identified microglia as the prominent source of complement C1qA (Fig. 
2.4b), but other cellular sources of C1q as well as the other members (C1qB, C1qC, C1r, 
C1s, C2, C4, C3) of the classical cascade have not been examined. Of note, animals 
deficient in complement C3 are more susceptible to WNV-NY99 and show higher CNS 
viral burdens, however this susceptibility occurs via loss of virologic control in the 
periphery35. Whether complement C3 might also affect other neurobiological processes 
during CNS viral infections is unknown. 
Over the past 5-10 years there has been significant debate over the pathogenicity 
of microglia139,140. Important studies have begun to describe the critical role of microglia 
and key molecules they express under normal, healthy CNS conditions for proper 
neuronal circuit formation and memory function101,89. But under neuropathologic 
conditions, as resident phagocytes and major sources of cytokines141, they are almost 
always observed within areas of CNS injury and inflammation, and thus often considered 
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guilty by association. Recent work, however, points to several neuroprotective roles for 
microglia during neuroinflammation including the displacement of inhibitory synapses to 
aid in neuronal survival during inflammation142 and increased monitoring of synapses 
during ischemic injury88. In our model of WNV encephalitis and recovery, microglia are 
clearly involved in pruning (glutamatergic) mossy fiber synapses, which is linked to the 
deficits in spatial memory performance as evidenced by transcriptional profiling (Fig. 
2.2g) and to greater synapse elimination in WNV-infected mice with poor spatial memory 
(Fig 2.3b). However, in the setting of a neurotropic viral infection, elimination of synapses 
may be advantageous for the prevention of transsynaptic viral spread or to prevent 
infected neurons from issuing excitotoxic signals. Indeed, retrograde and anterograde 
spread of WNV has been observed within peripheral neurons28. Several other neurotropic 
viruses, including Rabies virus and Herpes Simplex virus (HSV) types 1 and 2, are well 
known for their ability to gain CNS access via peripheral nerves and subsequent 
retrograde, transsynaptic spread into CNS neurons143,144. Of interest, HSV-1 produces  
glycoprotein C, a protein which binds and antagonizes complement C3145, which may 
allow it to travel through networks of neurons undetected. In the setting of neurotropic 
viral infection, loss of synapses, which readily regenerate, may be preferable to significant 
neuronal loss. Further studies are warranted to determine if the complement-dependent, 
microglial, synaptic pruning pathway is capable of preventing neuron-to-neuron spread of 
WNV and other neurotropic viruses. 
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Methods 
Animals 
8-10 week-old male and female mice were used at the outset of all experiments. 
C57BL/6J mice were obtained from Jackson Laboratories. C3 -/-  mice (> 10 generations 
backcrossed to C57Bl/6) were obtained from Dr. John Atkinson (Washington University), 
CX3CR1-GFP +/- mice (>10 generations backcrossed to C57Bl/6) were obtained from 
Dr. Richard Ransohoff (Lerner Research Institute, Cleveland Clinic Foundation), µMT -/- 
mice (C57Bl/6 background) were obtained from Dr. Michael Diamond (Washington 
University), and IL-34 -/- mice (C57Bl/6 background) were obtained from Dr. Marco 
Colonna (Washington University). All experimental protocols were performed in 
compliance with the Washington University School of Medicine Animal Safety Committee 
(protocol# 20140122). 
 
Mouse models of WNV infection 
Footpad: (WNV-NY99) The WNV strain 3000.0259 was isolated in New York in 2000146 
and passaged once in C6/36 Aedes albopictus cells to generate an insect cell–derived 
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stock. 100 plaque forming units (pfu) of WNV-NY99 were delivered in 50 uL to the footpad 
of anaesthetized mice. 
 
Intracranial: “WNV-NS5-E218A,” which harbors a single point mutation in the 2’O-methyl-
transferase gene, was obtained from Dr. Michael Diamond (Washington University) and 
passaged in vero cells as described previously8. Deeply anaesthetized mice were 
administered 104 pfu of WNV-NS5-E218A or 10 pfu of WNV-NY99 in 10 uL into the brain’s 
third ventricle via a guided 29 gauge needle. 
 
Stock titers of all viruses were determined by using BHK21 cells for viral plaque assay as 
previously described39. 
 
Leukocyte isolation and flow cytometry 
Cells were isolated from brains of WT mice at day 7 post-infection and stained with 
fluorescently conjugated antibodies to CD4, CD8, CD11b, and CD45 as previously 
described10. Data collection and analysis were performed with an LSRII flow cytometer 
using FlowJo software. 
 
Behavioral Testing 
Test for anxiety and locomotor behavior 
The Open Field Test was used to assess for baseline differences in anxiety or locomotor 
behavior, prior to Barnes Maze experiments. A standard Open Field arena 
(21.25”x21.25”, custom built) was used, consisting of a simple square box with a grid (6 
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squares/side) along the base. Animals were placed in the center of the arena and allowed 
to explore for 5 minutes. The arena was decontaminated with 70% ethanol between each 
trial. Locomotor activity was assessed by counting the number of lines the animal crossed 
during the testing period, and anxiety was assessed by counting the number of times the 
animal crossed through the center of the field. Behavior was recorded using a camera 
(Canon PowerShot SD1100 IS), and a blinded experimenter scored the trial.  
Test for visual spatial memory 
The Barnes Maze was used to assess for visual spatial memory. An elevated Barnes 
Maze (36” diameter, custom built) containing 19 empty holes and 1 target hole with a 
hidden escape chamber was used for testing (2” diameter holes were evenly spaced 
around the table, 2.5” from the edge). Visual cues were placed around the room and 
remained in the same location during the entire testing period. Mice were tested on the 
Barnes Maze over the course of 5 consecutive days. Each mouse received two trials per 
day, spaced exactly 30 minutes apart. For each trial, the mouse was placed in the center 
of the maze in a covered start box for 10 seconds, and removal of the box signaled the 
start of a trial. Each mouse was given 3 minutes to explore the maze and find the target 
hole. Mice that did not enter the target hole within 3 minutes were gently guided into the 
hole. After each trial, the mouse remained in the target hole for exactly 1 minute, and then 
was returned to its home cage. The maze was decontaminated with 70% ethanol between 
each trial. The numbers of errors (nose pokes over non-target holes) and the latency to 
find the target hole (amount of time elapsed before nose poke over target hole) were 
measured. Behavior was recorded using a camera (Canon Powershot SD1100IS), and a 
blinded experimenter scored the trials.  
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Immunohistochemistry 
Following perfusion with ice-cold PBS and 4% PFA, brains were immersion-fixed 
overnight in 4% PFA, followed by cryoprotection in 2 exchanges of 30% sucrose for 72 
hours, then frozen in OCT (Fisher). 9µm-thick fixed-frozen coronal brain sections were 
washed with PBS and permeabilized with 0.1% Triton X-100 (Sigma-Aldrich), and 
nonspecific Ab was blocked with 5-10% normal goat serum (Santa Cruz Biotechnology) 
for 1 h at room temperature. Mouse on Mouse kit (MOM basic kit, Vector) was used per 
manufacturers protocol when detecting synaptophysin (mouse, DAKO) to reduce 
endogenous mouse Ab staining. After block, slides were exposed to primary Ab or isotype 
matched IgG overnight at 4°C, washed with 0.2% FSG in PBS and incubated with 
secondary Abs for 1 h at room temperature. Nuclei were counterstained with ToPro3 
(Invitrogen) and coverslips were applied with vectashield (Vector). Immunofluorescence 
was analyzed using a Zeiss LSM 510 laser-scanning confocal microscope and 
accompanying software (Zeiss). Positive immunofluorescent signals were quantified 
using the public domain NIH Image analysis software, ImageJ.   
 
TUNEL staining was performed using the TMR-red in situ cell death detection kit (Roche) 
as per manufacturer’s instructions. C1qA staining was performed as previously 
described147. 
For synaptophysin staining, the mouse-on-mouse blocking kit (Vector Labs) was used as 
per manufacturer’s protocol. 
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Antibodies 
C1qa (Undiluted, described previously in147,148), WNV (1:100 described previously 10), 
GFAP (1:200 Invitrogen), IBA1 (1:100), IBA1 (for immuno-EM), MAP2 (1:100, Millipore), 
NeuN-biotin (1:100. Millipore), GFP (1:1000 Abcam), Synapsin-1 (1:200, Millipore), 
Synaptophysin (1:50. DAKO) 
 
Secondary antibodies conjugated to Alexa-488, Alexa-555, or Alexa-633 (Invitrogen) 
were used at 1:400 dilution. 
 
MRI 
Mice were intracardially perfused, first with ice-cold PBS and then with a mixture of 4% 
PFA and 10% Multihance (gadobenate dimeglumine, Bracco Diagnostics Inc, Princeton, 
NJ). Heads were further fixed in 4% PFA for 24 hours before being trimmed of extraneous 
tissue around the skull (to minimize the field of view). Heads were then placed in 1% 
Multihance in PBS until being imaged several days later. Ex vivo, whole-head MR imaging 
experiments were performed at 4.7 T using an Agilent/Varian (Santa Clara, CA) 
DirectDrive1 small-animal scanner. Data were collected with a custom-made RF foil coil 
that fit tightly around the head using a 3D, T1-weighted gradient echo sequence with the 
following parameters: TR = 105 ms, TE = 6 ms, flip angle = 90º, isotropic resolution = 
0.0625 mm, and scan time ~11 hrs. Regions of interest were manually drawn for the 
whole brain and hippocampus in ITK-SNAP (www.itksnap.org) from which volumes were 
calculated. 
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Harvest and purification of hippocampal RNA 
Mice were perfused with ice-cold PBS then hippocampi were dissected and snap-frozen 
in Tri-reagent (Ambion). Hippocampal tissue was then homogenized, and RNA purified 
as previously described149 using the RNA Ribopure kit (Ambion). RNA was precipitated 
with 25 mM Ammonium Acetate in 100% EtOH at -80 °C overnight, resuspended in 
RNAse-free H2O, and checked for purity. RNA was then treated with RNAse-out and 
DNAse I (invitrogen) as per manufacturer’s protocol.  
 
Microarray 
Hippocampal RNA was isolated as above and submitted to the Washington University 
Genome Technology Access Center. The total RNA quality and quantity were then 
determined by Agilent 2100 bioanalyzer (Agilent Technologies, Santa Clara, CA) and 
NanoDrop ND-1000 Spectrophotometer (Thermo Scientific NanoDrop, Wilmington, DE), 
according to manufacturer’s recommendations, respectively. A total of 400 ng of RNA 
transcripts from each sample were amplified by T7 linear amplification with the 
MessageAmp TotalPrep Amplification kit (Life Technologies-Ambion, Austin, TX). Then 
1.5 µg of each amplified and biotinylated RNA (aRNA) sample was hybridized onto 
Illumina MouseWG-6 v2 Expression Beadchips, followed by cy3 steptavidin–based 
staining, washing, and scanning, according to Illumina standard protocol.  The iScan 
scanner-created image data were loaded into Illumina GenomeStudio (v2011) for 
generation of expression values and data normalizations. Only those probes that were 
detected at p<0.05 in at least one of the samples were kept in downstream statistical 
analysis. Background subtracted and quantile normalized data were used in statistical 
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analysis for identification of differentially expressed genes with one-way ANOVA test 
using Partek Genomics Suite (v6.6, St. Louis, MO). All original p-values in the ANOVA 
analysis were adjusted by q-value based multiple test correction150. KEGG pathway 
analysis was performed using DAVID bioinformatics database functional annotation tool 
v.6.7 151. 
 
Real-time quantitative RT-PCR 
cDNA was synthesized using random hexamers, oligodT15, and MultiScribe reverse 
transcriptase (Applied Biosystems). A single reverse transcription master mix was used 
to reverse transcribe all samples in order to minimize differences in reverse transcription 
efficiency. The following conditions were used for reverse transcription: 25°C for 10 min, 
48°C for 30 min, and 95°C for 5 min. 
 
For calculation of WNV-E protein (positive and negative strand), Taqman primer-probes 
were used and copies were calculated based on a standard curve generated from a WNV-
E protein plasmid as previously described9. For all other primer sets, PCR reactions were 
prepared using Power SYBR Green PCR mastermix. Calculated copies were normalized 
against copies of the housekeeping gene, GAPDH. 
 
 
Quantification of synapses 
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ImageJ was used to threshold confocal images, draw region of interest encompassing 
the CA3 mossy fibers, and quantify either percent area of synaptophysin staining or 
number of synaptophysin+ puncta between 0.5 and 5 square microns in area. 
 
Electron microscopy 
Mice were perfused with 4% PFA, the brain was removed, and immersion fixed for 24 
hours at RT.  Tissue was washed in PBS, and 100µm sections were cut from regions of 
interest using a vibratome.  Sections were incubated in 0.5% gelatin, 5% horse serum, 
and 0.01% saponin in PBS for 5 hours on a rotator at RT.  Sections were then incubated 
for 48 hours at 4°C on rotator with rabbit anti-Iba1 (1:600; Wako).  After washing in dPBS, 
sections were incubated overnight at 4°C on rotator with donkey anti-rabbit biotinylated 
secondary antibody, (1:500; Rockland) in 0.5% gelatin and 5% horse serum in dPBS.  
Sections were again washed, and then incubated with streptavidin-HRP (1:1000; 
Rockland, S000-03) for 3 hours at RT, followed by another wash.  HRP was visualized 
using the DAB Substrate Kit (Cell Marque,957D) for 5 minutes, washed and then fixed 
with 2%PFA, 2.5% glutaraldehyde, in PBS for 30 mins, followed by a wash in PBS.  
Sections were post-fixed in 1% osmium tetroxide in PBS for 30 minutes at RT, washed in 
PBS, and then dehydrated in sequential concentrations of ethanol for 30 minutes each.  
Sections were then infiltrated with 1:1 Spurr’s resin and 100% ethanol overnight on a 
rotator, followed by two changes in pure Spurr’s resin over 24 hours.  Sections were 
embedded with Aclar film (EMS, 50425), and polymerized at 60°C for 48 hours.  The 
hippocampus was trimmed from the polymerized section, glued to a previously prepared 
block of Spurr’s resin, and allowed to cure for at least 24 hours. Using a Diatome ultra 
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45° diamond knife and a LEICA Ultracut UC7, blocks were sectioned at 500nm to confirm 
location of the tissue and the positivity of antibodies.  Once confirmed, 90nm sections 
were cut and picked up onto 200 hex mesh, formvar-carbon coated copper grids (Ted 
Pella, 01800-F). Images were digitally captured using a JEOL 1200 EX II Transmission 
Electron Microscope with AMT digital camera. 
 
Three-dimensional reconstruction of confocal Z-stack images 
Confocal Z-stack images taken with a Zeiss LSM 510 META microscope at 63x 
magnification, consisting of at least 10 images were transformed into 3-D reconstruction 
movies using Volocity 3D image analysis software (PerkinElmer). 
 
Super-resolution microscopy of presynaptic terminals 
9 micron fixed-frozen sections were stained for the glutamatergic presynaptic marker, 
VGlut1 and complement C1qA. Z-stack images were then taken using a Zeiss super-
resolution microscope and projection images were generated using Zeiss Zen analysis 
software. 
 
Human Tissue 
Human autopsy hippocampal tissue embedded in paraffin was obtained from St. Louis 
University Medical Center (St. Louis, MO) and Presbyterian / St. Luke’s Medical Center 
(Denver, CO). Sections were first deparaffinized and then boiled in sodium citrate buffer 
for antigen retrieval before staining with anti-synaptophysin antibody (DAKO, 1:50) 
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In situ Hybridization 
Fluorescent in situ hybridization was performed on 9um coronal brain sections which were 
4% PFA-fixed and frozen. C1qA and NSE was used as double mRNA staining and Iba1 
as immune-staining. C1qA and NSE anti-sense RNA was made and labeled with cyanine 
and fluorescein, respectively, using an RNA labeling kit (Roche). C1qA was synthesized 
from pCMV SPORT6 C1qA plasmid from Openbiosystem reference # MMM1013-63584 
(which was digested with SalI and transcribed with T7 Promoter). The RNA probes were 
incubated over night at 64 degree Celsius, and then detected with antibodies against 
fluorescein and cyanine (Roche). The staining reaction was then amplified with a TSA 
staining Kit (PerkinElmer). A Rabbit anti-Iba1 (Wako) was used to label the microglia and 
detected with a Donkey anti Rabbit 647 (Life technologies). Stained sections were then 
imaged and analyzed on a Zeiss AX10 fluorescent microscope. 
 
Statistical analysis 
Results from Barnes Maze spatial learning and memory studies were compared by 
repeated measures two-way ANOVA. Microarray data was analyzed by one-way ANOVA 
and fold change greater than 1.5, false discovery rate q < 0.05 to correct for multiple 
hypotheses for Mock vs. WNV-all comparison, p < 0.05 for WNV-good vs WNV-poor. All 
other experiments compared by student’s two-tailed T-test, with * p < 0.05 considered as 
significant. 
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Figure 2.1 Spatial learning and memory impairments and activated microglia 
persist beyond one month post-infection. (a) At days 46-50 post WNV-NS5-E218A or 
mock-infection, WNV-infected mice commit more errors (nose poke in non-target hole) in 
the Barnes Maze spatial learning and memory task and take more time (b) before finding 
the target hole as measured in the average of two trials per day for 5 days (*** p < 0.001, 
* p <0.05 by repeated measures two-way ANOVA). At 45 days post-infection (p.i.), mice 
were observed for 2 minutes on the open-field test and were found to be equivalent to 
mock-infected controls both in locomotor activity (c) and in exploratory anxiety (d), as 
measured by center crosses. (e) Immunohistochemistry for IBA1 and Topro3 (nuclear) 
reveals persistent microglial activation within the hippocampal dentate gyrus and CA3 of 
WNV-NS5-E218A-infected mice at 7, 25, and 52 days p.i. compared to age-matched 
mock-infected controls (mean of 2 experiments). Scale bar = 50 µm. (f) Representative 
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images from immunohistochemistry for CD68 within the hippocampal CA3 at 7 days post-
mock or WNV-NS5-E218A infection in CX3CR1-GFP heterozygous mice shows 
increased CD68 staining both within CX3CR1-positive microglia (white arrowheads) as 
well as in CX3CR1-negative infiltrating macrophages (red arrowheads) (scalebar = 10 
µm). (g) Representative images and quantification of CD68 staining at day 7 post mock 
or WNV-NS5-E218A infection in wild type mice (scalebar = 10 µm).*** p < 0.001, * p < 
0.05, by Student’s two-tailed T-test 
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Figure 2.2 Transcriptional expression profile of good and poor spatial learners 
during WNV recovery. (a) Heatmaps showing relative expression of significantly altered 
genes (FDR q < 0.05, FC > 1.5) generated from a hippocampal microarray analysis of 
mock vs. WNV-NS5-E218A-recovered mice at 25 days post-infection. (b) Validation of 
select genes and pathways in unique set of mice by quantitative PCR. (c) Scatter plot 
depicting number of errors on day 2 of Barnes Maze testing, the most sensitive learning 
period, showing good and poor learners among the WNV-NS5-E218A recovery group. 
(d) PCA plots from the microarray analysis shows unique transcriptional expression 
profiles among mock-infected controls and good and poor learners recovering from WNV-
NS5-E218A.(e) Relative expression heatmap from microarray of the top 50 upregulated 
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and 50 downregulated (by fold change) genes comparing WNV-recovery good and poor 
learners. (f) Venn diagram of microarray data showing number of genes significantly 
altered from mock-infected controls (p < 0.05, FC > 1.5) which are unique or shared 
among WNV-recovery good or poor learners. (g) Validation by quantitative PCR of select 
genes significantly altered between WNV-good and WNV-poor learners using a unique 
set of mice (n = 3-6 mice per group). (h) Copies of positive-strand (non-replicating strand) 
mRNA for the WNV envelope protein present at day 25 post-infection show no difference 
in amount of persistent positive-strand viral RNA between good and poor learners. *** p 
< 0.001, ** p < 0.01, * p < 0.05 by Two-tailed student’s T-test. 
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Figure 2.3 WNV causes a loss in hippocampal CA3 synapses in mice and humans.  
(a) Immunohistochemistry for the presynaptic marker, synaptophysin, reveals a reduction 
in hippocampal CA3 synapses at 7 days post-infection in wildtype mice infected with 
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WNV-NS5-E218A compared to age-matched mock-infected controls, but IL34 -/- mice 
infected with WNV-NS5-E218A do not show any significant loss of synapses compared 
to mock-infected controls. Scalebar = 10 µm. (b) Immunohistochemistry for the 
glutamatergic presynaptic marker, Vglut1, reveals a reduction in CA3 synapses which 
persists to 25 days post-infection and is most severe in WNV-infected mice who perform 
poorly on the Barnes Maze spatial memory task. Scalebar = 10 µm. (c) 
Immunohistochemistry for synaptophysin and GFP within CX3CR1-GFP +/- mice, used 
as a marker of microglia, show multiple synaptophysin+ puncta localized within microglial 
cytoplasm. Scalebar = 10 µm. (d) Immunohistochemistry for synaptophysin and IBA1 
within the hippocampal CA3 reveals a greater percentage of synaptophysin+ area 
colocalized within IBA1+ microglia in WNV-NS5-E218A-infected WT mice at 7 and 25 
days post-infection. Lower-left panel depicts engulfed synapses (magenta to white 
gradient scale based on colocalization) within IBA1+ cells including a high-power inset. 
Scalebar = 20 µm. (e) At day 7 post WNV-NS5-E218A infection, electron microscopy with 
immune-DAB staining for the microglia/macrophage marker, IBA1, reveals 
morphologically distinct IBA1-positive cells often possessing phagosomes which contain 
40nm synaptic vesicles (red arrowheads in e and ei)  and which have processes that 
surround nearby synapses (ei). Scalebars = 1 µm.(f) Immunohistochemistry for 
synaptophysin within human autopsy cases shows that acute WNV encephalitis patients 
show significant reductions in hippocampal CA3 synaptophysin+ area compared to age 
and sex-matched controls. Scalebar = 10 µm. * p < 0.05 by Two-tailed student’s T-test. 
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Figure 2.4 Classical complement cascade in neurons and microglia controls WNV-
mediated synapse elimination. (a) Hippocampal mRNA levels of C1qA are upregulated 
at days 7, 25, and 52 post WNV-NS5-E218A infection. (b) Fluorescent in situ hybridization 
shows upregulation of C1qA mRNA within IBA1-positive cells at 7 days post infection with 
WNV-NS5-E218A. scalebar = 50 µms (c) Immunohistochemistry reveals colocalization 
(white arrowheads) between C1qA protein and the microglial/macrophage marker, IBA1. 
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Immunohistochemistry for C1qA protein shows C1qA deposition on WNV antigen-positive 
(infected) neurons at 7 d.p.i. (d) and on VGlut1-positive synapses 7 and 25 d.p.i. (e: 
confocal with quantification & f: super-resolution microscopy images). (g) 
Immunohistochemistry for the presynaptic terminal marker, synaptophysin, in 
complement C3-null mice at 7 days post infection reveals that C3-null mice are resistant 
to WNV-NS5-E218A-mediated synapse loss within the mossy fiber region of the 
hippocampal CA3. Synapse numbers quantified as number of 0.5 – 25 sq. µm  
synaptophysin+ puncta per mm2, normalized to age-matched mock-infected controls. ** 
p < 0.01, * p < 0.05 by student’s two-tailed t-test. 
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Figure 2.S1. Murine intracranial infection with attenuated WNV-NS5-E218A induces 
similar viral loads and inflammatory response as wildtype WNV-NY99, but greater 
overall survival. (a) Plaque assay performed on dissected brain tissue at various time 
points post-infection (p.i.) with either footpad (FP) infection with 102 pfu of WNV-NY99 or 
intracranial (IC) infection with 104 pfu WNV-NS5-E218A shows peak titers (plaque 
forming units per gram of tissue) of WNV-NS5-E218A at 6 days p.i., which are cleared 
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from the hippocampus by 15 days p.i. (b) Survival curve of mice infected at 8 weeks old 
via the FP with WNV-NY99 or IC with WNV-NY99 or WNV-NS5-E218A. (c-d) Flow 
cytometric analysis of dissected cortex, hippocampus (plots for CD45 and CD11b shown 
in c) and cerebellum at 6 days p.i. with WNV-NY99 and WNV-NS5-E218A show similar 
increases (d) in numbers of leukocytes (CD45-high), lymphocytes (CD45-high, CD11b-
low), and activated macrophages and microglia (CD45-high, CD11b-high) compared to 
mock-infected controls (n = 4 mice per group). (e) Immunohistochemistry and counts for 
TUNEL staining with the neuronal marker, NeuN, during peak infection (day 7) reveals 
small, but non-significant increases in numbers of TUNEL+ NeuN+ cells in WNV-NS5-
E218A (n=5) compared to mock-infected controls (n = 4) (DG = Dentate Gyrus - pictured, 
CTX = Entorhinal, Perirhinal, and Visual Cortex). Two-tailed student’s t-test used to 
determine significance (p < 0.05). 
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Figure 2.S2. At >50 days post-WNV-NS5-E218A infection, mice do not show any 
appreciable loss in brain volume or neuron numbers. (a) QPCR for positive strand 
(non-replicating strand) WNV Envelope protein message remaining in hippocampal tissue 
at 7, 25, and 52 days post-infection (d.p.i) (n = 3-5 mice per group). (b) 
Immunohistochemistry and counts for hippocampal TUNEL staining with the neuronal 
marker, NeuN, at 52 d.p.i shows that there are equivalent levels of NeuN+ and total 
apoptotic cells in Mock compared to WNV-NS5-E218A (n=5) compared to mock-infected 
controls (n = 3) (scalebar = 20 µm). (c) Immunohistochemistry and quantification of 
number of NeuN+ neurons within the Dentate Gyrus and width of the granule cell layer at 
52 days post-mock (n=4) or WNV-NS5-E218A (n=5) infection (scalebar = 100 µm). (d) 
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Post-mortem mouse brains were imaged by MRI at 52 days post-infection to determine 
tissue volume of the hippocampus (outlined in red) and total brain (n = 5 mice per group) 
(scalebar = 1 mm). Student’s two-tailed T-test was used to determine significance of 
experiments (* p < 0.05).  
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Figure 2.S3. Following recovery from WNV-NS5-E218A infection, mice do not show 
gross pathological differences or astrocyte activation. (a) Immunohistochemistry for 
the reactive astrocyte marker, GFAP, shows that WNV-NS5-E218A-infected mice do not 
exhibit greater hippocampal astrocyte activation than mock-infected controls at 52 days 
post-infection. (b) H&E staining shows intact hippocampal CA1 pyramidal cell layer, and 
occasional microglial nodules (arrowhead) surrounded by several lymphocytes at 52 days 
post-infection in WNV-NS5-E218Arecovered mice. (c) During acute WNV-NS5-E218A 
infection (day 7), there is no increase in engulfment of synaptophysin+ puncta by S100β+ 
astrocytes as quantified by percent of synapses colabeled with S100β in the hippocampal 
CA3 (Not significant by student’s t-test). 
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Figure 2.S4. Acute synapse loss during infection with WNV-NY99 (a) 
Immunohistochemistry for the presynaptic marker, Synapsin1 within the hippocampal 
CA3 reveals a significant reduction in CA3 synapses during acute wild type (WNV-NY) 
footpad infection (day 8 post-infection) (b) During acute WNV-NS5-E218A infection (day 
7), there is no change in hippocampal colocalization of synaptophysin+ puncta with 
S100β+ astrocytes as quantified by percent of synapses colabeled with S100β (Not 
significant by student’s t-test). 
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Figure 2.S5. WNV infection of human hippocampal CA2/CA3 neurons with loss of 
synapses within the hippocampal CA1 and the Entorhinal Cortex. (a) H&E staining 
(top) and WNV-antigen immunohistochemistry (bottom) show WNV-antigen located 
within CA2/CA3 pyramidal cell neuron cell bodies (arrows) and neurites (arrowheads). (b, 
c) Immunohistochemistry for synaptophysin within human autopsy cases shows that 
acute WNV encephalitis patients show trends towards reductions in synaptophysin+ area 
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within the hippocampal CA1 (b) and entorhinal cortex (c) compared to age and sex-
matched controls (scalebar = 20 µm). Note: In 1 WNV encephalitis patient sample, the 
entorhinal cortex was not able to be quantified. Significance determined by two-tailed 
student’s two-tailed t-test (not significant). 
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Figure 2.S6. No differences in endogenous mouse IgG within the hippocampal CA3 
region at 25 days post infection with WNV-NS5-E218A. No significant differences 
(Student’s Two-tailed T-test, all comparisons) were detected between groups (Mock, 
WNV-good, and WNV-poor learners) from immunohistochemistry and quantifications of 
total endogenous mouse IgG or mouse IgG colocalization with the post-synaptic marker, 
Homer1. 
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Pathway 
gene
s p- val 
Adj 
p-val Select Genes within pathway 
Systemic lupus 
erythematosus 
23 1.9E-14 0.000 
HIST1H4M, HIST1H2AD, GRIN2B, HIST1H4A, C2, HIST1H4I, C4A, C4B, 
FCGR4, H2-AB1, TRIM21, FCGR3, C1QA, IGHG, CD86, FCGR2B, H2-
DMA 
Antigen 
processing and 
presentation 
20 2.0E-12 0.000 
H2-K1, CD8B1, H2-M3, H2-D1, IFI30, H2-AB1, CTSS, H2-Q6, H2-Q7, 
CD74, B2M, TAPBP, H2-OA, PSME1, TAP2, TAP1, H2-EB1, H2-AA, H2-
T23, 
Allograft rejection 14 2.9E-09 0.000 
H2-K1, H2-M3, H2-D1, H2-AB1, H2-Q6, H2-Q7, H2-Q8, IGHG, CD86, H2-
OA, H2-EB1, H2-AA, H2-T23, H2-T10, H2-DMA, IGH-VJ558 
Cytokine-cytokine 
receptor 
interaction 
26 6.2E-09 0.000 
CCL2, IL21R, CXCL9, CXCR3, CCL5, TNFRSF4, CCL7, CXCL10, 
IL10RA, TNFRSF18, CSF3R, IL2RG, IFNGR1, CD27, CSF1R, TGFBR2, 
CCL19 
Natural killer cell 
mediated 
cytotoxicity 
18 2.2E-08 0.000 
H2-K1, PIK3CG, PTPN6, CD244, H2-D1, FCGR4, VAV1, HCST, FCGR3, 
IGHG, RAC2, LCK, PLCG2, FCER1G, H2-T23, IFNGR1, IGH-VJ558, 
SH3BP2 
Viral myocarditis 16 2.4E-08 0.000 
H2-K1, H2-M3, H2-D1, H2-AB1, H2-Q6, H2-Q7, H2-Q8, IGHG, CD86, 
RAC2, H2-OA, CASP8, H2-EB1, H2-AA, H2-T23, H2-T10, H2-DMA 
Autoimmune 
thyroid disease 
14 4.8E-08 0.000 
H2-K1, H2-M3, H2-D1, H2-AB1, H2-Q6, H2-Q7, H2-Q8, IGHG, CD86, H2-
OA, H2-EB1, H2-AA, H2-T23, H2-T10, H2-DMA, IGH-VJ558 
Chemokine 
signaling pathway 
21 7.4E-08 0.000 
PIK3CG, CCL2, ADCY7, CXCL9, CXCR3, STAT1, CCL5, CCL4, VAV1, 
PRKCD, WAS, CCL7, STAT2, CXCL10, RAC2, CCR5, CXCL13, CXCL16, 
CX3CR1 
Graft-versus-host 
disease 
12 3.2E-07 0.000 
H2-K1, H2-M3, H2-D1, H2-AB1, H2-Q6, H2-Q7, H2-Q8, CD86, H2-OA, 
H2-EB1, H2-AA, H2-T23, H2-T10, H2-DMA 
Primary 
immunodeficiency 
10 3.2E-07 0.000 
IGHG, CD8B1, CD3D, CD3E, TAP2, TAP1, TNFRSF13B, LCK, IL2RG, 
IGH-VJ558 
Cell adhesion 
molecules (CAMs) 
18 7.1E-07 0.000 
H2-K1, CD8B1, H2-M3, H2-D1, H2-AB1, H2-Q6, H2-Q8, VCAM1, CD86, 
H2-OA, CD274, H2-EB1, CD2, H2-T10, CD6, H2-DMA, SELPLG 
Type I diabetes 
mellitus 
12 7.7E-07 0.000 
H2-K1, H2-M3, H2-D1, H2-AB1, H2-Q6, H2-Q7, H2-Q8, CD86, H2-OA, 
H2-EB1, H2-AA, H2-T23, H2-T10, H2-DMA 
B cell receptor 
signaling pathway 
13 
 
1.3E-06 0.000 
PIK3CG, PTPN6, IFITM1, CD72, VAV1, IGHG, FCGR2B, RAC2, PLCG2, 
PIK3AP1, CD79B, INPP5D, IGH-VJ558 
Intestinal immune 
network for IgA 
production 
10 
 
1.2E-05 
 
0.000 
 
IGHG, CD86, TNFSF13B, H2-OA, LOC641240, TNFRSF13B, H2-EB1, 
H2-AA, H2-AB1, H2-DMA, IGH-VJ558 
Toll-like receptor 
signaling pathway 
13 1.3E-05 0.000 
PIK3CG, TLR2, CXCL9, CCL5, TLR6, STAT1, CCL4, CXCL10, CD86, 
MYD88, IRF5, IRF7, CASP8 
Hematopoietic cell 
lineage 
12 1.4E-05 0.000 
CD3G, CD8B1, CD3D, CD3E, CD9, IGHG, H2-EB1, CD2, CSF3R, H2-AA, 
IGH-VJ558, CSF1R 
Asthma 8 2.3E-05 0.000 IGHG, H2-OA, H2-EB1, H2-AA, FCER1G, H2-AB1, H2-DMA, IGH-VJ558 
Cytosolic DNA-
sensing pathway 
8 6.5E-04 0.004 DDX58, IRF7, TREX1, CCL5, CASP1, CCL4, CXCL10, ADAR 
Fc gamma R-
mediated 
phagocytosis 
10 1.3E-03 0.007 
PIK3CG, IGHG, RAC2, FCGR2B, PLCG2, INPP5D, WAS, PRKCD, VAV1, 
IGH-VJ558 
Fc epsilon RI 
signaling pathway 
9 1.6E-03 0.009 
PIK3CG, IGHG, RAC2, PLCG2, FCER1G, INPP5D, PRKCD, VAV1, IGH-
VJ558 
Complement and 
coagulation 
cascades 
8 4.0E-03 0.021 C1QA, VWF, C1QB, C4A, C4B, SERPING1, C2, PROS1, C1QC 
Jak-STAT 
signaling pathway 
11 8.1E-03 0.040 
IRF9, PIK3CG, PTPN6, IL10RA, IL21R, CSF3R, IL2RG, STAT1, CISH, 
IFNGR1, STAT2 
 
Table 2.S1 – Pathway analysis of genes altered by WNV-NS5-E218A compared to 
mock-infected controls at 25 days post-infection. KEGG pathway analysis using 
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DAVID bioinformatics database functional annotation tool v.6.7. Analysis generated with 
list of genes having greater than 1.5 fold change and false discovery rate q value of less 
than 0.05 in Mock vs. WNV-all analysis. Adjusted p-values determined by Benjamini false 
discovery rate.  
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Rank Gene Definition Fold ch p 
1 LOC636875 PREDICTED: similar to Ig kappa chain V-V region L7 precursor (LOC636875) 8.68 0.037 
2 LOC100046552 PREDICTED: similar to Unknown (protein for MGC:103328) (LOC100046552) 7.81 0.043 
3 IGHG PREDICTED: Immunoglobulin heavy chain (gamma polypeptide) (Ighg) 6.91 0.004 
4 IGH-VJ558  5.99 0.013 
5 LOC381774  5.79 0.036 
6 IGK-V5 PREDICTED: immunoglobulin kappa chain variable 5 (V5 family) (Igk-V5) 5.51 0.042 
7 IGK-V5 PREDICTED: immunoglobulin kappa chain variable 5 (V5 family) (Igk-V5) 5.46 0.010 
8 LOC207685 PREDICTED: hypothetical protein LOC207685, transcript variant 1 (LOC207685) 4.75 0.018 
9 IGH-VJ558 PREDICTED: immunoglobulin heavy chain (J558 family) (Igh-VJ558) 4.71 0.016 
10 LOC100047316 PREDICTED: similar to anti-MOG Z12 variable light chain (LOC100047316) 4.15 0.007 
11 AI324046  4.00 0.035 
12 AI324046  3.98 0.041 
13 LOC386520  3.80 0.006 
14 IGHV1S119_L33961_IG_HEAVY_VARIABLE_1S119_14 3.78 0.020 
15 AI324046  3.57 0.019 
16 LOC380801  3.53 0.011 
17 LOC385109  3.47 0.018 
18 SAA3 serum amyloid A 3 (Saa3) 3.46 0.046 
19 LOC100047162 PREDICTED: similar to immunoglobulin kappa-chain (LOC100047162) 3.33 0.033 
20 LOC640696 PREDICTED: similar to Ig heavy chain V-I region V35 precursor (LOC640696) 3.29 0.032 
21 LOC636752 PREDICTED: similar to Ig kappa chain V-VI region NQ2-6.1 (LOC636752) 3.28 0.002 
22 AI324046  3.26 0.042 
23 IGLC2_J00595_IG_LAMBDA_CONSTANT_2_14 3.14 0.006 
24 LOC669053 PREDICTED: similar to Ig kappa chain V-V region MPC11 precursor (LOC669053) 3.04 0.034 
25 LOC630302 PREDICTED: similar to VH283 protein (LOC630302) 3.00 0.037 
26 IGHG PREDICTED: Immunoglobulin heavy chain (gamma polypeptide), transcript variant 1 (Ighg) 2.97 0.030 
27 LOC100048770 PREDICTED: similar to Ig H-chain V-JH1-region (LOC100048770) 2.96 0.020 
28 IGHV1S133_AF304553_IG_HEAVY_VARIABLE_1S133_89 2.93 0.001 
29 GBP2 guanylate binding protein 2 (Gbp2) 2.84 0.037 
30 SLPI secretory leukocyte peptidase inhibitor (Slpi) 2.77 0.035 
31 LOC385277  2.71 0.026 
32 SERPING1 serine peptidise inhibitor 1 (C1 inhibitor) 2.68 0.043 
33 UBD ubiquitin D (Ubd) 2.52 0.046 
34 IGHV1S59_L17134_IG_HEAVY_VARIABLE_1S59_150 2.46 0.008 
35 LOC383196 PREDICTED: hypothetical LOC383196 (LOC383196) 2.44 0.002 
36 IGKV4-71_AJ231218_IG_KAPPA_VARIABLE_4-71_20 2.38 0.017 
37 1110059M19RIK  2.37 0.040 
38 LOC383196 PREDICTED: hypothetical LOC383196 (LOC383196) 2.37 0.001 
39 LOC100042270 PREDICTED: similar to Unknown (protein for MGC:41421) (LOC100042270) 2.30 0.001 
40 DISP2 dispatched homolog 2 (Drosophila) (Disp2) 2.27 0.008 
41 TSPO translocator protein (Tspo) 2.26 0.026 
42 IFITM1 interferon induced transmembrane protein 1 (Ifitm1) 2.25 0.013 
43 PSMB8  2.25 0.036 
44 CD274 CD274 antigen (Cd274) 2.20 0.039 
45 TUBA6  2.17 0.041 
46 IGHV1S30_X02462_IG_HEAVY_VARIABLE_1S30_12 2.16 0.046 
47 IGKV4-91_AJ231229_IG_KAPPA_VARIABLE_4-91_29 2.13 0.033 
48 CXCL10 chemokine (C-X-C motif) ligand 10 (Cxcl10) 2.12 0.045 
49 PIK3AP1 phosphoinositide-3-kinase adaptor protein 1 (Pik3ap1) 2.10 0.044 
50 H2-T10 histocompatibility 2, T region locus 10 (H2-T10) 2.10 0.039 
51 IGHV1S34_X02467_IG_HEAVY_VARIABLE_1S34_71 2.10 0.050 
52 MVP major vault protein (Mvp) 2.09 0.039 
53 CYTIP cytohesin 1 interacting protein (Cytip) 2.09 0.025 
54 PRG4  2.06 0.033 
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55 LOC434609 PREDICTED: similar to Ig heavy chain V region VH558 A1/A4 precursor (LOC434609) 2.05 0.001 
56 CD52  2.04 0.030 
57 EGR2  2.03 0.025 
58 IGHA_J00475$V00785_IG_HEAVY_CONSTANT_ALPHA_135 2.02 0.001 
59 TSPO translocator protein (Tspo) 1.99 0.030 
60 SULF1 sulfatase 1 (Sulf1) 1.96 0.037 
61 4930533K18RIK  1.93 0.006 
62 2810046M22RIK  1.91 0.041 
63 LY6C1 lymphocyte antigen 6 complex, locus C1 (Ly6c1) 1.89 0.037 
64 CDKN1A cyclin-dependent kinase inhibitor 1A (P21) (Cdkn1a) 1.89 0.046 
65 HDC histidine decarboxylase (Hdc) 1.88 0.013 
66 GIMAP6 GTPase, IMAP family member 6 (Gimap6) 1.86 0.013 
67 VAMP8 vesicle-associated membrane protein 8 (Vamp8) 1.85 0.022 
68 TCEA3  1.83 0.015 
69 LCK lymphocyte protein tyrosine kinase (Lck) 1.83 0.031 
70 MIA1  1.82 0.044 
71 GM1276 PREDICTED: gene model 1276, (NCBI) (Gm1276) 1.82 0.047 
72 IFITM1 interferon induced transmembrane protein 1 (Ifitm1) 1.81 0.038 
73 TRAF1  1.81 0.021 
74 IGHV1S12_J00507_IG_HEAVY_VARIABLE_1S12_239 1.81 0.001 
75 H2-DMA histocompatibility 2, class II, locus DMa (H2-DMa) 1.81 0.047 
76 LOC100048556 PREDICTED: similar to monocyte chemoattractant protein-5, (LOC100048556) 1.80 0.039 
77 SYNPO  1.80 0.030 
78 TNF tumor necrosis factor (Tnf) 1.78 0.037 
79 LOC100048556 PREDICTED: similar to monocyte chemoattractant protein-5, (LOC100048556) 1.78 0.023 
80 TAPBP  1.78 0.005 
81 LOC223672  1.77 0.041 
82 SELL selectin, lymphocyte (Sell) 1.75 0.043 
83 1700024G13RIK  1.73 0.003 
84 LBP lipopolysaccharide binding protein (Lbp) 1.73 0.040 
85 NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (Nfkbia) 1.72 0.042 
86 LOC100038882 PREDICTED: hypothetical protein LOC100038882 (LOC100038882) 1.72 0.031 
87 IL1A interleukin 1 alpha (Il1a) 1.72 0.015 
88 ECM1 extracellular matrix protein 1 (Ecm1) 1.69 0.048 
89 MIA1 melanoma inhibitory activity 1 (Mia1) 1.69 0.031 
90 ONECUT3 one cut domain, family member 3 (Onecut3) 1.69 0.040 
91 TRIOBP  1.68 0.045 
92 CPT1A  1.68 0.014 
93 INPP5D inositol polyphosphate-5-phosphatase D (Inpp5d) 1.68 0.047 
94 LOC100040402 PREDICTED: hypothetical protein LOC100040402 (LOC100040402) 1.67 0.039 
95 TAP2 transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) (Tap2) 1.67 0.028 
96 2600011C06RIK  1.65 0.044 
97 TNFSF13B tumor necrosis factor (ligand) superfamily, member 13b (Tnfsf13b) 1.65 0.044 
98 B930097J01RIK  1.64 0.027 
99 TNFRSF12A tumor necrosis factor receptor superfamily, member 12a (Tnfrsf12a) 1.64 0.040 
100 LASS2 LAG1 homolog, ceramide synthase 2 (Lass2) 1.64 0.004 
 
Table 2.S2 – Transcriptionally altered genes by microarray, WNV-poor higher than 
WNV-Good. Genes higher in WNV-poor than in WNV-good (top 100 genes by fold 
change and p value <0.05) 
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Ran
k Gene Definition Fold ch p 
1 LOC232065  2.49 0.019 
2 CYFIP2 cytoplasmic FMR1 interacting protein 2 (Cyfip2) 1.97 0.000 
3 PHF14 PHD finger protein 14 (Phf14) 1.95 0.009 
4 5430417J04RIK  1.86 0.009 
5 AU021092 expressed sequence AU021092 (AU021092) 1.82 0.002 
6 PPAP2A phosphatidic acid phosphatase 2a (Ppap2a), transcript variant 2 1.78 0.013 
7 ROCK2 Rho-associated coiled-coil containing protein kinase 2 (Rock2) 1.78 0.002 
8 TRMT2B TRM2 tRNA methyltransferase 2 homolog B (S. cerevisiae) (Trmt2b) 1.74 0.006 
9 CHRNA1 cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) (Chrna1) 1.73 0.000 
10 SQLE squalene epoxidase (Sqle) 1.73 0.021 
11 TTC30A1 tetratricopeptide repeat domain 30A1 (Ttc30a1) 1.72 0.004 
12 SC4MOL sterol-C4-methyl oxidase-like (Sc4mol) 1.69 0.046 
13 2610044O15RIK RIKEN cDNA 2610044O15 gene (2610044O15Rik) 1.68 0.013 
14 GPR155 G protein-coupled receptor 155 (Gpr155) XM_921852 XM_921857 1.65 0.019 
15 CCDC25 coiled-coil domain containing 25 (Ccdc25) 1.65 0.001 
16 WDR17 WD repeat domain 17 (Wdr17) 1.65 0.042 
17 PDGFRL platelet-derived growth factor receptor-like (Pdgfrl) 1.65 0.023 
18 RLBP1L1 retinaldehyde binding protein 1-like 1 (Rlbp1l1) 1.65 0.000 
19 B230107J06RIK  1.63 0.003 
20 LOC382964  1.63 0.020 
21 STX3 syntaxin 3 (Stx3), transcript variant B 1.63 0.005 
22 CYB561D2 cytochrome b-561 domain containing 2 (Cyb561d2) 1.63 0.012 
23 PDIK1L PDLIM1 interacting kinase 1 like (Pdik1l) 1.63 0.001 
24 RASL12 RAS-like, family 12 (Rasl12) 1.63 0.004 
25 LOC100046855 PREDICTED: similar to BKLF (LOC100046855) 1.63 0.001 
26 6430531H12RIK  1.63 0.003 
27 TESC  1.62 0.018 
28 4631422C13RIK PREDICTED: RIKEN cDNA 4631422C13 gene (4631422C13Rik) 1.62 0.015 
29 UBE3A ubiquitin protein ligase E3A (Ube3a), transcript variant 2 1.61 0.030 
30 GUCY2E  1.61 0.005 
31 DOC2B double C2, beta (Doc2b) 1.60 0.035 
32 ARHGEF9 CDC42 guanine nucleotide exchange factor (GEF) 9 (Arhgef9) 1.60 0.016 
33 CCNJL cyclin J-like (Ccnjl) 1.58 0.001 
34 SEMA6C sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C (Sema6c) 1.58 0.029 
35 TPPP tubulin polymerization promoting protein (Tppp) 1.58 0.005 
36 DOCK9 dedicator of cytokinesis 9 (Dock9), transcript variant 1 1.58 0.012 
37 4921521J11RIK  1.58 0.026 
38 GRIN1 glutamate receptor, ionotropic, NMDA1 (zeta 1) (Grin1) 1.57 0.025 
39 SIAH1B seven in absentia 1B (Siah1b) 1.57 0.043 
40 ALDH3A2  1.57 0.010 
41 A430010E21RIK  1.56 0.007 
42 DOC2B double C2, beta (Doc2b) 1.56 0.014 
43 TERF2IP telomeric repeat binding factor 2, interacting protein (Terf2ip) 1.56 0.029 
44 TCF20 transcription factor 20 (Tcf20) 1.56 0.022 
45 KLRB1B killer cell lectin-like receptor subfamily B member 1B (Klrb1b) 1.56 0.020 
46 VTI1A  1.56 0.001 
47 CHST7 carbohydrate (N-acetylglucosamino) sulfotransferase 7 (Chst7) 1.56 0.019 
48 2010011I20RIK RIKEN cDNA 2010011I20 gene (2010011I20Rik) 1.56 0.039 
49 PCDHAC1 protocadherin alpha subfamily C, 1 (Pcdhac1) 1.55 0.025 
50 4930503L19RIK RIKEN cDNA 4930503L19 gene (4930503L19Rik) XM_001001515 1.55 0.046 
51 HSPA12A heat shock protein 12A (Hspa12a) 1.55 0.045 
52 LOC100047052 PREDICTED: similar to Aptx protein (LOC100047052) 1.55 0.006 
53 GALNT3  1.55 0.010 
54 ALG8 asparagine-linked glycosylation 8 homolog (yeast, alpha-1,3-glucosyltransferase) (Alg8) 1.54 0.012 
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55 LOC235086  1.54 0.014 
56 TTLL9 tubulin tyrosine ligase-like family, member 9 (Ttll9), transcript variant 1 1.54 0.043 
57 PPP2R2C protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), gamma isoform (Ppp2r2c) 1.54 0.018 
58 ROBO1 roundabout homolog 1 (Drosophila) (Robo1) 1.53 0.048 
59 ELFN2 leucine rich repeat and fibronectin type III, extracellular 2 (Elfn2) 1.53 0.020 
60 EG406223 predicted gene, EG406223 (EG406223) 1.53 0.012 
61 2210008F06RIK PREDICTED: RIKEN cDNA 2210008F06 gene (2210008F06Rik) 1.53 0.039 
62 PVRL3 poliovirus receptor-related 3 (Pvrl3), transcript variant alpha 1.53 0.044 
63 RNF123 ring finger protein 123 (Rnf123) 1.53 0.000 
64 5830435K17RIK  1.52 0.025 
65 RTN4 reticulon 4 (Rtn4), transcript variant 1 1.52 0.016 
66 SEMA3E sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E (Sema3e) 1.52 0.018 
67 PPP4R4 protein phosphatase 4, regulatory subunit 4 (Ppp4r4) 1.52 0.030 
68 COVA1 cytosolic ovarian carcinoma antigen 1 (Cova1) 1.51 0.016 
69 6030419L17RIK  1.51 0.003 
70 POPDC3 popeye domain containing 3 (Popdc3) 1.51 0.049 
71 XKR7 X Kell blood group precursor related family member 7 homolog (Xkr7) 1.51 0.031 
72 CCDC94 coiled-coil domain containing 94 (Ccdc94) 1.51 0.024 
73 E130309D02RIK RIKEN cDNA E130309D02 gene (E130309D02Rik) 1.51 0.004 
74 1700020L24RIK RIKEN cDNA 1700020L24 gene (1700020L24Rik) 1.51 0.006 
75 SGTB small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta (Sgtb) 1.50 0.003 
76 CHD5 chromodomain helicase DNA binding protein 5 (Chd5), transcript variant 1 1.50 0.012 
77 RIC3 resistance to inhibitors of cholinesterase 3 homolog (C. elegans) (Ric3), transcript variant 2 1.50 0.019 
78 KCNIP2 Kv channel-interacting protein 2 (Kcnip2), transcript variant a 1.50 0.008 
79 NCKAP1 NCK-associated protein 1 (Nckap1) 1.50 0.017 
80 GRHL1 grainyhead-like 1 (Drosophila) (Grhl1) 1.50 0.044 
81 D030013I16RIK RIKEN cDNA D030013I16 gene (D030013I16Rik) 1.49 0.005 
82 ARL3 ADP-ribosylation factor-like 3 (Arl3) 1.49 0.032 
83 PI15 peptidase inhibitor 15 (Pi15) 1.49 0.012 
84 SNAP91 synaptosomal-associated protein 91 (Snap91) 1.49 0.017 
85 SEZ6L2 seizure related 6 homolog like 2 (Sez6l2) 1.49 0.018 
86 BC030500 cDNA sequence BC030500 (BC030500) 1.48 0.042 
87 6030405A18  1.48 0.028 
88 MCRS1 microspherule protein 1 (Mcrs1) 1.48 0.011 
89 LAMA4 laminin, alpha 4 (Lama4) 1.48 0.026 
90 GDA guanine deaminase (Gda) 1.48 0.018 
91 PARP1 poly (ADP-ribose) polymerase family, member 1 (Parp1) 1.48 0.004 
92 MAPK8IP1 mitogen-activated protein kinase 8 interacting protein 1 (Mapk8ip1) 1.48 0.023 
93 DLX2 distal-less homeobox 2 (Dlx2) 1.48 0.020 
94 ISLR2 immunoglobulin superfamily containing leucine-rich repeat 2 (Islr2) 1.48 0.003 
95 TGFB2 transforming growth factor, beta 2 (Tgfb2) 1.48 0.008 
96 LOC100045726 PREDICTED: hypothetical protein LOC100045726 (LOC100045726) 1.48 0.009 
97 9130213B05RIK RIKEN cDNA 9130213B05 gene (9130213B05Rik) 1.48 0.041 
98 NUFIP1 nuclear fragile X mental retardation protein interacting protein 1 (Nufip1) 1.47 0.022 
99 CYB5D2 cytochrome b5 domain containing 2 (Cyb5d2) 1.47 0.005 
100 ACO1 aconitase 1 (Aco1) 1.47 0.040 
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Table 2.S3 – Transcriptionally altered genes by microarray, WNV-good higher than 
WNV-Poor. Genes higher in WNV-good than in WNV-poor (top 100 genes by fold change 
and p value < 0.05) 
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 Pathway p val Altered genes 
1 Primary immunodeficiency 6.3E-04 IGHG, TAP2, LCK, AIRE, IGH-VJ558 
2 Cytokine-cytokine receptor interaction 9.3E-04 
IFNAB, TNF, CCL2, TNFRSF12A, IL21R, IL11RA1,  
TNFRSF4, CXCL10, CCL6, LEP, TNFRSF1A, FAS, IL1A 
3 Natural killer cell mediated cytotoxicity 2.6E-03 
IFNAB, IGHG, CD244, TNF, ARAF, LCK, FAS, 
KLRA3, 
4 Calcium signaling pathway 4.2E-03 
IGHG, EDNRB, PDE1C, TACR1, CAMK2D,  
PLCD4, PLCD1, CHRNA7, CAMK2A, IGH-VJ558 
5 Allograft rejection 5.4E-03 
LOC100048770, IGHG, TNF, H2-T10, FAS, H2-DMA, 
 IGH-VJ558 
6 Graft-versus-host disease 5.4E-03 TNF, H2-T10, FAS, H2-DMA, IL1A, KLRA3 
7 Apoptosis 7.1E-03 TNFRSF1A, IRAK3, TNF, NFKBIA, FAS, BIRC2, IL1A 
8 Autoimmune thyroid disease 1.3E-02 
IFNAB, LOC100048770, IGHG, H2-T10, FAS, H2-DMA,  
IGH-VJ558 
9 B cell receptor signaling pathway 2.0E-02 
LOC100048770, IGHG, IFITM1, NFKBIA, PIK3AP1,  
INPP5D, IGH-VJ558 
 
10 
 
 
Intestinal immune network for IgA 
production 2.1E-02 
LOC100048770, IGHG, LOC100048841, TNFSF13B,  
H2-DMA, IGH-VJ558 
11 Hematopoietic cell lineage 2.4E-02 
LOC100048770, IGHG, TNF, ITGA1, IL11RA1, IL1A,  
IGH-VJ558 
12 Asthma 2.6E-02 LOC100048770, IGHG, TNF, H2-DMA, IGH-VJ558 
13 NOD-like receptor signaling pathway 3.3E-02 TNF, CCL2, ERBB2IP, NFKBIA, BIRC2 
14 Type I diabetes mellitus 3.5E-02 TNF, H2-T10, FAS, H2-DMA, IL1A 
15 Adipocytokine signaling pathway 4.2E-02 LEP, TNFRSF1A, TNF, NFKBIA, CPT1A 
 
 
Table 2.S4. Pathway analysis of genes significantly higher in WNV-poor spatial 
memory performers compared to WNV-good at 25 days post-infection. KEGG 
pathway analysis using DAVID bioinformatics database functional annotation tool v.6.7. 
Analysis generated with list of genes having greater than 1.5 fold change and p value of 
less than 0.05 in WNV-poor vs. WNV-good analysis. Adjusted p-values determined by 
Benjamini false discovery rate.  
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 Pathway p Altered genes 
1 Long-term potentiation 0.002 GRM5, GRIN2B, GRIN1, PPP3CA, PPP1CC, PPP1CB, PRKCB 
2 Calcium signaling pathway 0.013 TRPC1, PHKB, PDE1A, CACNA1G, RYR2, PRKCB, CACNA1B 
3 Axon guidance 0.014 EPHA5, SEMA6C, PLXNA4, ROCK2, ROBO1, SEMA3E, SLIT2 
4 Wnt signaling pathway 0.027 TBL1XR1, CCND1, ROCK2, SIAH1B, SIAH1A, CUL1, PRKCB 
5 Terpenoid backbone biosynthesis 0.030 LOC100040592, MVD, FDPS 
6 MAPK signaling pathway 0.035 MAPT, CACNA1G, PLA2G6, FGF13, MAPK8IP1, TGFB2 
7 Butanoate metabolism 0.036 LOC100040592, GAD1, PDHB, ALDH3A2 
8 Glyoxylate and dicarboxylate metab. 0.039 GLYCTK, ACO1, AFMID 
9 Steroid biosynthesis 0.043 TM7SF2, SQLE, SC4MOL 
10 p53 signaling pathway 0.046 CCND1, SIAH1B, SIAH1A, CCNG2, ATM 
 
Table 2.S5. Pathway analysis of genes significantly higher in WNV-good spatial 
memory performers compared to WNV-poor at 25 days post-infection. KEGG 
pathway analysis using DAVID bioinformatics database functional annotation tool v.6.7. 
Analysis generated with list of genes having greater than 1.5 fold change and p value of 
less than 0.05 in WNV-good vs. WNV-poor analysis. Adjusted p-values determined by 
Benjamini false discovery rate. 
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Group Age Sex PMI 
Cause of 
Death Other findings / Comorbidities 
  
 
 
 
 
DG 
 
 
 
 
 
CA2/3 
 
 
 
 
 
CA1  
 
 
 
 
 
EC 
 
WNV 46 f 15 WNV encephalitis History of non-Hodgkin's lymphoma, bone-marrow transplant recipient 
 
- 
 
+++ 
 
  - 
 
 - 
 
 51 f 22 WNV encephalitis 
S. aureus infection, history of rheumatoid arthritis, lupus, and 
immunosuppressive therapy 
 
- 
 
+++ 
 
  - 
 
 -  
 62 m 20 WNV encephalitis 
History of cardiac, lung, and brain sarcoidosis, cardiomegaly, 
atherosclerosis, steroid treatment 
 
- 
 
+ 
 
  - 
 
 +  
 75 m ? WNV encephalitis History of mantle cell lymphoma, bone-marrow transplant recipient 
 
- 
 
- 
 
  - 
 
 -  
 79 f 16 WNV encephalitis Atherosclerosis, history of pyelonephritis, rheumatoid arthritis 
 
- 
 
- 
 
  - 
 
 - 
 
 
Mean: 62.6  18.3   
     
           
Group Age Sex PMI 
Cause of 
Death Other findings / Comorbidities 
 
 
DG 
 
 
CA2/3 
 
 
CA1  
 
 
EC 
 
Control 47 f 21 Cardiac arrest 
Emphysema, kidney atrophy, history of congestive heart failure, multiple 
small vessel embolisms 
 
- 
 
- 
 
  - 
 
 - 
 
 56 f 15 Cardiogenic shock 
Coronary artery disease, pericardial metastatic carcinoma, history of 
hepatitis C, transplant recipient 
 
- 
 
- 
 
  - 
 
 - 
 
 57 m 4 Cardiac arrest Atherosclerosis, history of prostate cancer, emphysema, hypertension 
 
- 
 
- 
 
  - 
 
 - 
 
 60 m 17 Cardiac arrest 
History of cardiac arrest, atherosclerosis, cardiomegaly, 
emphysematous changes 
 
- 
 
- 
 
  - 
 
 - 
 
 60 f 12 Cardiac arrest History of cerebral ischemic stroke (MCA), gram-negative sepsis 
 
- 
 
- 
 
  - 
 
 - 
 
 65 m 17 PEA cardiac arrest 
Bronchopneumonia, chronic obstructive pulmonary disease, history of 
myocardial infarction 
 
- 
 
- 
 
  - 
 
 - 
 
 72 m 25 
 
PEA cardiac arrest 
Atherosclerosis, history of congestive heart failure, history of 
hypotension 
 
- 
 
- 
 
  - 
 
 - 
 
 84 f 39 Undetermined 
Renal disease, myocyte hypertrophy, pulmonary fibrosis, history of 
sepsis 
 
- 
 
- 
 
  - 
 
 - 
 
Mean: 62.6  18.8   
     
 
 
Table 2.S6 – Human post-mortem tissue. Relevant information on human autopsy 
cases used in this study, including age, sex, post-mortem interval (PMI) in hours, cause 
of death, and other comorbidities noted. Abbreviations used: Pulseless electrical activity 
(PEA), Dentate Gyrus (DG), Entorhinal Cortex (EC). Scoring = negative (-), mild (+), 
moderate (++) or severe (+++) for West Nile virus antigen immunostaining. 
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CHAPTER 3 – Alterations to hippocampal and subventricular zone adult 
neurogenesis during West Nile virus encephalitis 
 
Abstract 
Cognitive sequelae have been reported to occur following the neuroinvasive 
infections of several neurotropic viruses including Japanese Encephalitis virus152, St. 
Louis Encephalitis virus153, acute sporadic encephalitis caused by Herpes Simplex154, and 
more recently, West Nile virus12,14,15. West Nile Virus (WNV) is a mosquito-borne flavivirus 
capable of infecting and killing mature neurons and eliciting antiviral immune responses 
throughout the central nervous system (CNS). In the United States, WNV has been 
responsible for over 13,000 reported cases of encephalitis and meningitis since its 
emergence in 1999. Of interest, over 50% of patients who recover from WNV 
neuroinvasive disease (WNND) suffer cognitive sequelae, including confusion, 
depression, and memory impairments for a year or longer beyond the course of acute 
viral infection. Memory impairments and depression have both been linked to alterations 
in adult neurogenesis, suggesting WNV impacts on this process. Previous studies by our 
group, using a well-established murine model, have determined that chemoattractant 
molecules expressed by WNV-infected neurons are responsible for recruiting 
lymphocytes to promote viral clearance and survival40. Here we report that during WNND 
recovery, significantly fewer new granule cell neurons are born within the hippocampal 
dentate gyrus, as revealed by BrdU-labeling. And although neuronal progenitor cells 
(NPCs) are not direct targets of WNV infection, their homeostatic levels of proliferation, 
differentiation, and migration were significantly altered. Using immunohistochemistry and 
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flow cytometry coupled with in vivo BrdU labeling during acute WNV infection, we found 
NPCs within the subventricular (SVZ) and subgranular (SGZ) neurogenic zones 
generated fewer new neuroblasts, but greater numbers of astrocytes, an effect which 
slowly recovers over about 45 days. This effect was dependent upon Interleukin-1 
receptor (IL-1R)  signaling, which we have previously shown to be necessary for 
promotion of viral clearance by T lymphocytes10.  Lastly, IL-1R deficient mice were 
resistant to the WNV-mediated impairment in spatial learning and memory observed in 
wild type mice (Vasek and Klein, chapter 2) via the Barnes maze task at 45 days post 
infection, suggesting that the alterations to neuronal progenitor cell homeostasis during 
adult neurogenesis may underlie long term cognitive consequences of WNND. 
 
Introduction 
 West Nile Virus (WNV) has recently experienced resurgence in the United States. 
Both the number of total cases and the number of neuroinvasive cases more than 
quadrupled in 2012 compared to 201111. In the acute stage of infection, patients suffering 
from WNV encephalitis or meningitis can experience confusion, fatigue, loss of motor 
control, memory loss, coma, and a mortality rate of about 8-10%12. Unfortunately, of the 
many patients who survive neuroinvasive WNV, about half experience long term cognitive 
sequelae including depression, memory impairments, and motor impairments for several 
months to years beyond the episode of symptomatic infection14–16,97,126. To date, there 
have been no published studies that investigate the mechanistic causes of long-term 
cognitive sequelae or the extent of damage and repair that occurs beyond the acute 
phase of WND. 
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 Once WNV has entered the central nervous system, it preferentially infects and 
replicates within neurons and can cause apoptosis via caspase-3 induction20,21. A robust 
encephalitic response follows CNS WNV infection, in which T cells are crucial for viral 
clearance and survival37,38; however it is possible that this infiltration of leukocytes into 
the CNS may cause additional neuron damage. Likely, the specific brain regions which 
are variably infected by WNV might dictate the symptoms and sequelae experienced by 
patients in the short and long-term, respectively. The hippocampus, an area often infected 
in both human and murine WNV encephalitis19,155, is essential for spatial and contextual 
memory formation. Inputs from the entorhinal cortex enter the hippocampus and relay 
through the dentate gyrus, CA3, and CA198. Damage to hippocampal neurons or their 
synaptic connections could restrict proper spatial memory formation or memory recall.  
 Another component of hippocampal learning involves the process of adult 
neurogenesis, which occurs within the hippocampal dentate gyrus (DG) and the 
subventricular zone (SVZ)156. Within the DG, adult neural stem cells give rise to 
astrocytes and intermediate neuronal progenitors, the latter of which proliferate and 
differentiate into neuroblasts. These neuroblasts migrate into the granule cell layer of the 
DG, mature into granule cell neurons and integrate into the hippocampal circuit over the 
course of a few weeks71,157. Although the precise extent to which adult neurogenesis 
contributes to spatial learning is a field which needs further careful investigation, it is clear 
that voluntary running and environmental enrichment increase neurogenesis as well as 
performance in several spatial learning and memory tasks in rodents 158–160. Furthermore, 
ablation of neurogenesis by X-ray irradiation leads to impaired spatial learning in the 
Barnes Maze72. The fact that many WNND patients experience memory impairments for 
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months to years beyond viral clearance suggests a chronic condition with either sustained 
damage or limited repair. 
 The inflammatory cytokine Interleukin 1 (IL-1), which has two main forms, IL-1α 
and IL-1β, has also been shown to impact on cognitive function in the context of 
neuroinflammation. While IL-1 is known to be a key player in orchestrating the CNS 
immune response, including onset of fever161, it also plays a role in spatial learning and 
memory-related behavior162. Indeed, injection of IL-1β into the brain impairs spatial 
learning, contextual fear memory, and adult neurogenesis163–165. Of interest, IL-1R-
deficient mice are slow to learn the Morris water maze task, display a deficit in long-term 
potentiation in the hippocampus, and exhibit longer freezing times during contextual fear 
memory testing166,167. Although several studies have investigated impacts of IL-1 on 
hippocampal-based learning and behavior, few have done so in a setting of physiological 
IL-1 induction, such as during CNS infection. 
 In this study we utilize a previously described murine model of WNND recovery 
replete with spatial memory impairments out to 50 days post-infection (Chapter 2). 
Utilizing a brdU pulse-chase experiment, we show that adult WNV-recovered mice 
experience a loss in newborn dentate granule cell neurons during the period of spatial 
learning and memory impairments. Using flow cytometry, we were able to show that this 
neuronal loss is due to a reduction in the proliferation/differentiation of neural progenitors 
along the neuronal lineage during the acute phase of WNV infection, which lasts out to at 
least 30 days post-infection. Interestingly, neuronal progenitors within the SVZ suffered a 
similar reduction in neuroblast proliferation during WNND, as well as an additional 
aberration in their migratory patterns. Wild type mice infected and recovered from WNV-
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NS5-E218A infection displaying impaired spatial learning and memory were found to have 
upregulated transcripts relating to IL-1R signaling. Furthermore, IL-1R -/- mice did not 
experience the WNV-mediated alterations to neuronal progenitor cell proliferation and 
importantly, also did not show a WNV-mediated impairment to spatial learning and 
memory in the Barnes Maze task. This study highlights a potential pathway and 
mechanism underlying impairments to memory during WNND. 
 
Results and Discussion 
 To better understand the cognitive sequelae experienced by many patients who 
have recovered from WNV encephalitis we established a murine model of WNV recovery 
to study cognitive impairments. Because footpad infection with wildtype WNV (WNV-NY) 
leads to variable levels of CNS infection and direct intracranial infection with WNV-NY 
virus is 100% lethal, we intracranially inoculated mice with 104 pfu of an attenuated mutant 
form of WNV (2’O methyltransferase-E218A)9,168. The mutant WNV-E218A does infect 
neurons when administered via this route, replicates within the CNS, and induces an 
antiviral encephalitic response, however over 90% of mice survive and recover from the 
encephalitis. Intracranial (i.c.) infection with WNV-E218A is capable of infecting all brain 
regions infected by WNV-NY including the hippocampus, cortex, striatum, cerebellum, 
and brainstem and capable of inducing neuronal apoptosis9.  
 Because the process of adult neurogenesis contributes to hippocampal spatial 
learning and memory71, we evaluated the generation of new neurons during WNV 
encephalitis and the recovery period. We administered BrdU during the peak of WNV 
encephalitis for a period of 4 days (days 3-7), and then allowed mice to recover for 52 
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days. WNV-recovered mice exhibited fewer BrdU-labeled neurons within the dentate 
gyrus granule cell layer than mock-infected controls (Fig. 3.1). 
 One possible explanation of fewer new neurons after the recovery period of WNV 
encephalitis is that neuroblasts are dying before reaching maturity. In agreement with 
previous studies, we confirmed that neural stem cells and intermediate neuronal 
progenitors were not permissive to WNV infection128, and observed that less than 1% of 
doublecortin-expressing neuroblasts were infected in vivo in both the SVZ and SGZ (Fig. 
3.2). Furthermore rates of neuroblast apoptosis during acute WNND were equivalent to 
mock-infected controls (data not shown). The few infected neuroblasts which were 
observed within the DG were located within the granule cell layer, suggesting that these 
may be late-stage neuroblasts as they are transitioning into immature neurons. Late-
stage neuroblasts exhibit many of the same properties as neurons including, receptors, 
filament proteins, and cellular processes (e.g. axon formation and the beginning of 
dendrite formation), thus potentially explaining the ability of WNV to infect them. 
 Another explanation for reduced neurogenesis includes the alteration in the rate of 
neuronal progenitor cell proliferation. To test this, mock-infected versus WNV-NY-infected 
or WNV-E218A-infected mice were administered BrdU during the peak of encephalitis, 
followed by either immunohistochemical (Fig. 3.3a) or flow cytometric (Fig. 3.3b) 
evaluation of hippocampal neuronal progenitors, as described previously149. Infections 
with either wild type WNV (NY-99) via the peripheral footpad route (Fig. 3.3a), via the 
intracranial infection route, or attenuated WNV-NS5-E218A all led to fewer BrdU-labeled 
neuroblasts at 6-8 days post-infection (Fig. 3.3b). This reduction in neuroblast-genesis 
was assessed over the course of WNND recovery, at 6, 15, and 30 days post-infection 
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(after normalization to age-matched controls) and found that deficits persist until at least 
day 15 within the hippocampus and day 30 within the SVZ (Fig. 3.3c). 
Alterations in the proliferation rates of neural progenitors could result in changes 
to the overall pool of stem cells over time. Using-GFP-expressing mice, we counted the 
numbers of Nestin and GFAP-double positive cells remaining within the hippocampal 
SGZ at 45 days post-infection, but found no differences in the numbers of neural stem 
cells expressed by mock and WNV-NS5-E218A recovered mice (data not shown). 
 To further investigate the potential for an alteration in cell fate / differentiation of 
early stage progenitors, we tested to see if fewer neuronal progenitors were produced in 
favor of more glial progenitors within the hippocampus of WNV-infected mice. To test this, 
mock-infected versus WNV-NY-infected or WNV-E218A-infected mice were administered 
BrdU during the peak of encephalitis followed by flow cytometric evaluation of 
hippocampal neuronal progenitors and astrocytes 48 hours later (Fig. 3.4). Infections with 
either wild type WNV (NY-99) or attenuated WNV-NS5-E218A led to more BrdU-labeled 
gfap-expressing astrocytes at 7 days post infection than mock-infected controls (Fig. 3.4). 
 The migration of neuroblasts to their proper targets remains an additional important 
component of functional adult neurogenesis71. Upon examining neuroblasts within the 
SVZ from WNV-infected mice, we additionally discovered an abberant migration pattern 
expressed by these cells, in that more DCX+ cells were found at distances greater than 
30 microns from the walls of the lateral ventricle (Fig. 3.5). This phenomenon has 
previously been observed in striatal ischemic models169, but has not been previously 
described in viral models of CNS infection. 
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  Since adult neural stem cells within the DG can give rise to both the astrocyte and 
neuronal lineages in vivo170, our results suggest that there is either a reduction in 
proliferation of neuronal progenitors in combination with an increase in proliferation of 
astrocyte progenitors, or there is a shift in the differentiation of neural stem cells, causing 
more daughter cells to enter the astrocyte lineage in favor of the neuronal lineage. The 
cytokines, Interleukin-1α (IL-1α) and Interleukin-1β (IL-1β), have been shown to induce 
neural stem and progenitor cells in vitro to favor the astrocyte rather than neuronal 
lineage171. Furthermore, two members of the IL-1 receptor (IL-1R) signaling pathway, 
Caspase-1, which cleaves and activates IL-1β, and IL-1α, were identified by a microarray 
screen in chapter 2 as being highly expressed in mice with sever spatial memory 
impairments during WNND. In additional cohorts of wild-type mice, we validated this 
microarray by quantitative PCR and found significant hippocampal upregulation of both 
genes specifically within the WNV-poor spatial memory performing mice compared to 
mock-infected controls (Fig. 3.6).  
Next, we tested if the WNV-mediated reduction in neuroblast proliferation would 
occur in mice lacking IL-1 signaling utilizing IL-1R -/- mice. Mock-infected and WNV-NS5-
E218A-infected IL-1R -/- mice were administered BrdU during the peak of encephalitis, 
followed by flow cytometric evaluation of hippocampal neuronal progenitors. In contrast 
to the reduction in neuroblast genesis observed in wild type animals, IL-1R -/- were 
resistant to changes in neuroblast proliferation rates (Fig 3.7).  
If reductions to neurogenesis was underlying the spatial memory impairments 
exhibited by WNND recovering mice (Fig 2.1a), then it might be expected that IL-1R -/- 
mice recovering WNND may exhibit preservation of spatial learning and memory. Thus, 
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after i.c. infection with WNV-NS5-E218A, we allowed IL-1R -/- mice to recover for a month 
beyond viral clearance (46 days post infection) and tested their ability to spatially locate 
and remember the location of a target hole in a Barnes maze over the course of 10 trials 
held twice daily for 5 days. In contrast to wild type mice, IL-1R -/- mice recovering from 
WNND performed equally well on the Barnes Maze spatial learning task (Fig. 3.8).  
One significant caveat to the experiments utilizing IL-1R -/- mice is that in other 
spatial learning tasks (e.g. morris water maze), IL-1R -/- mice have altered baseline 
spatial memory performance than wild type mice and it is possible that the same 
pathway(s) which becomes impaired during WNND recovery of wild type animals is 
already impaired in adult IL-1R -/- animals. Experiments with IL-1R pathway antagonists 
performed in wild type mice may be warranted to confirm the aforementioned results. 
Taken together, our results show that during the acute phase of viral infection, the 
proliferation, migration, and differentiation fates of neural progenitor cells are altered 
during the recovery period of WNV encephalitis. Interestingly, mice deficient in IL-1R 
signaling are resistant to both the altered npc proliferation as well as spatial memory 
impairments which are observed in wild type WNND mice. The combinatorial effect of 
synapse loss (chapter 2) and reduced neurogenesis (chapter 3) is likely to seriously 
impact hippocampal spatial learning and memory long beyond the initial episode of 
infection. 
 
Materials and methods 
Animals 
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5-8 week-old male mice were used at the outset of all experiments. C57BL/6J mice were 
obtained from Jackson Laboratories. IL-1R -/-  mice (> 10 generations backcrossed to 
C57Bl/6) were obtained from Jackson Laboratories. Nestin-GFP mice (> 10 generations 
backcrossed to C57Bl/6) were obtained from Dr. Gregory Enikolopov (Cold Spring Harbor 
Laboratories). All experimental protocols were performed in compliance with the 
Washington University School of Medicine Animal Safety Committee (protocol# 
20140122). 
 
Mouse models of WNV infection 
Footpad: (WNV-NY99) The WNV strain 3000.0259 was isolated in New York in 2000 
(Ebel et al., 2001) and passaged once in C6/36 Aedes albopictus cells to generate an 
insect cell–derived stock. 100 plaque forming units (pfu) of WNV-NY99 were delivered in 
50 uL to the footpad of anaesthetized mice. 
 
Intracranial: “WNV-NS5-E218A,” which harbors a single point mutation in the 2’O-methyl-
transferase gene, was obtained from Dr. Michael Diamond (Washington University) and 
passaged in vero cells as described previously8. Deeply anaesthetized mice were 
administered 104 pfu of WNV-NS5-E218A or 10 pfu of WNV-NY99 in 10 uL into the brain’s 
third ventricle via a guided 29 gauge needle. 
 
Stock titers of all viruses were determined by using BHK21 cells for viral plaque assay as 
previously described103. 
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Antibodies 
WNV (1:100 described previously10), GFAP (1:200 Invitrogen), Doublecortin (1:150 Cell 
Signaling), BrdU (1:50 for flow cytometry BD Biosciences), BrdU (1:200 for IHC Abcam) 
NeuN-biotin (1:100 Millipore), GFP (1:1000 Abcam),  
 
Secondary antibodies conjugated to Alexa-488, Alexa-555, or Alexa-647 (Invitrogen) 
were used at 1:400 dilution. 
 
Immunohistochemistry 
Following perfusion with ice-cold PBS and 4% PFA, brains were immersion-fixed 
overnight in 4% PFA, followed by cryoprotection in 2 exchanges of 30% sucrose for 72 
hours, then frozen in OCT (Fisher). 9µm-thick fixed-frozen coronal brain sections were 
washed with PBS and permeabilized with 0.1% Triton X-100 (Sigma-Aldrich), and 
nonspecific Ab was blocked with 5-10% normal goat serum (Santa Cruz Biotechnology) 
for 1 h at room temperature. Mouse on Mouse kit (MOM basic kit, Vector) was used per 
manufacturers protocol when detecting synaptophysin (mouse, DAKO) to reduce 
endogenous mouse Ab staining. After block, slides were exposed to primary Ab or isotype 
matched IgG overnight at 4°C, washed with 0.2% FSG in PBS and incubated with 
secondary Abs for 1 h at room temperature. Nuclei were counterstained with ToPro3 
(Invitrogen) and coverslips were applied with vectashield (Vector). Immunofluorescence 
was analyzed using a Zeiss LSM 510 laser-scanning confocal microscope and 
accompanying software (Zeiss). Positive immunofluorescent signals were quantified 
using the public domain NIH Image analysis software, ImageJ.   
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TUNEL staining was performed using the TMR-red in situ cell death detection kit (Roche) 
as per manufacturer’s instructions. C1qA staining was performed as previously 
described147. 
 
Flow cytometry 
Cells were isolated from brains of WT mice at day 6, 15, or 30 days post-infection and 
stained with fluorescently conjugated antibodies to CD45, BrdU, and Doublecortin as 
previously described149. Data collection and analysis were performed with an LSRII flow 
cytometer using FlowJo software. 
 
Real-time quantitative RT-PCR 
cDNA was synthesized using random hexamers, oligodT15, and MultiScribe reverse 
transcriptase (Applied Biosystems). A single reverse transcription master mix was used 
to reverse transcribe all samples in order to minimize differences in reverse transcription 
efficiency. The following conditions were used for reverse transcription: 25°C for 10 min, 
48°C for 30 min, and 95°C for 5 min. 
 
Behavioral Testing 
The Barnes Maze was used to assess for visual spatial memory. An elevated Barnes 
Maze (36” diameter, custom built) containing 19 empty holes and 1 target hole with a 
hidden escape chamber was used for testing (2” diameter holes were evenly spaced 
around the table, 2.5” from the edge). Visual cues were placed around the room and 
remained in the same location during the entire testing period. Mice were tested on the 
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Barnes Maze over the course of 5 consecutive days. Each mouse received two trials per 
day, spaced exactly 30 minutes apart. For each trial, the mouse was placed in the center 
of the maze in a covered start box for 10 seconds, and removal of the box signaled the 
start of a trial. Each mouse was given 3 minutes to explore the maze and find the target 
hole. Mice that did not enter the target hole within 3 minutes were gently guided into the 
hole. After each trial, the mouse remained in the target hole for exactly 1 minute, and then 
was returned to its home cage. The maze was decontaminated with 70% ethanol between 
each trial. The numbers of errors (nose pokes over non-target holes) and the latency to 
find the target hole (amount of time elapsed before nose poke over target hole) were 
measured. Behavior was recorded using a camera (Canon Powershot SD1100IS), and a 
blinded experimenter scored the trials.  
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Figures and Tables 
 
 
 
Fig 3.1. Fewer new neurons are born within the dentate gyrus during WNV-NS5-
E218A recovery. Mice were given an I.P. BrdU injection (75 mg/kg) every 12 hours for 
3.5 days (7 injections)  beginning at day 4 pi, then we waited until 52 days post-infection 
to sacrifice mice for immunohistochemistry analysis. Cells born during the period of BrdU 
labeling are labeled with anti-BrdU (red) and neurons are labeled with NeuN (green), 
nuclei are labeled with Dapi (blue).  Right: The number of BrdU+ NeuN+ cells per section 
of dentate gyrus were quantified and normalized to percent of mock-infected control. * p 
< 0.05 by student’s t-test. > 4 sections per animal analyzed 
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Fig 3.2 WNV Permissivity within Doublecortin-positive neuroblasts in vivo. 5 week 
old mice were infected via the footpad with 100 pfu of wild type WNV(NY99) and 
harvested for tissue collection on day 8 post infection. Immunohistochemistry is shown 
for West Nile antigen and the neuroblast marker, doublecortin (DCX) within the Dentate 
gyrus and Subventricular Zones (SVZ). Many WNV+ neurons can be seen within the 
granule cell layer (GCL) of the Dentate gyrus and the striatum neighboring the SVZ, 
however only 1 out of 4 animals showed any WNV and DCX-double positive cells (shown 
by white arrowhead, Left), resulting in a mean % of infection of less than 1% of total DCX+ 
cells. Within the Dentate gyrus, infected DCX+ cells were always located within the GCL 
– indicating that they are more mature neuroblasts or immature neurons. 
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Fig 3.3 Deficits in adult neurogenesis during WNV infection.  
Mice were given an i.p. BrdU injection (100 mg/kg) at 24 and 48 hours prior to harvest.  
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A) Immunohistochemistry shows fewer BrdU-labeled neuroblasts, marked by the marker, 
Doublecortin (DCX), within the SVZ at 8 days post-infection with WNV-NY via the footpad 
(100 pfu) compared to uninfected age-matched controls. B) The proliferation rates of 
neuroblasts were measured (% BrdU incorporation) within subventricular zone (SVZ) or 
hippocampus (HP) dissections from mice, and isolation of cells for flow cytometry. Shown 
are graphs of BrdU+ cells after gating on doublecortin+ cells at 6 days post intracranial 
infection with either wild type WNV-NY99, WNV-NS5-E218A, or saline (Mock). C) The 
proliferation rates of neuroblasts were measured by % of neuroblasts with BrdU 
incorporation using flow cytometry after gating on doublecortin+ cells at 6, 15, and 30 
days post WNV-NS5-E218A or mock infection. All data in (C) normalized to age-matched 
mock-infected controls to compensate for age-related alterations in neurogenesis. 
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Fig 3.4. Greater numbers of BrdU-labeled astrocytes neurons are born within the 
hippocampus during acute WNV encephalitis. Mice were given an i.p. BrdU injection 
(100 mg/kg) at 24 and 48 hours prior to harvest on day 6 pi. Left: Isolation of GFAP+ 
astrocytes and DCX+ neuroblasts by flow cytometry. Right: Percentage of GFAP+ 
astrocytes labeled with BrdU at day 6 post intracranial WNV-NY or WNV-E218A infection. 
** p < 0.01 by Two-tailed Student’s T-test. 
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Fig 3.5 Aberrant migration of SVZ neuroblasts during WNV infection. Age and sex-
matched uninfected mice or mice infected via the footpad with 100 pfu of WNV-NY (1999), 
were collected at 8 days post infection. Following immunohistochemichal staining for the 
neuroblast marker, Doublecortin (DCX), the number of DCX+ cells found greater than 30 
microns (depicted by white arrowheads) from the lateral ventricle wall were calculated. ** 
p < 0.01 by Two-tailed Student’s T-test. 
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Fig 3.6 Gene transcripts in the IL-1R signaling pathway are altered specifically in 
WNV-NS5-E218A-infected poor spatial learning mice. RNA from hippocampi was 
collected at day 25 post-infection from Mock, and WNV-NS5-E218A infected, recovering 
mice which exhibited good or poor spatial memory on the Barnes Maze task. NS = not 
significant, # = trend towards significance (0.10 > p > 0.05), *** = p < 0.001 by Two-tailed 
Student’s T-test.  
85 
 
 
 
Fig 3.7 IL-1R -/- mice are resistant to WNV-mediated alterations to neuroblast 
proliferation. The proliferation rates of neuroblasts were measured (% BrdU 
incorporation) within subventricular zone or hippocampus following dissection and 
isolation of cells for flow cytometry. Shown are graphs of % of BrdU+ cells after gating on 
doublecortin+ cells at 6 days post intracranial infection with WNV-NS5-E218A, or saline 
(Mock) and normalization against genotype and age-matched mock-infected controls. ** 
p < 0.01, *** p < 0.001 by Two-tailed student’s T-test. 
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Fig 3.8 IL-1R -/- WNV-E218A-infected mice do not harbor significant differences in 
spatial learning and memory via the Barnes Maze behavior task. Mice were infected 
with 104 pfu of WNV-NS5-E218A at 8 weeks of age and allowed to recover for 45 days 
before the initiation of Barnes Maze testing. Number of errors (nose poke in non-target 
hole) committed before finding the target hole in the Barnes Maze were measured twice 
per day and averaged, with an inter-trial interval of 30 minutes, over the course of 5 days 
of testing. Statistics: not significant by repeated measures two-way ANOVA. 
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Fig 3.S1. Flow Cytometry gating strategy. A) Following isolation and staining with Dapi 
and antibodies to CD45, Doublecortin, and BrdU, doublets were excluded, and the CD45-
negative population was utilized for further gates. B) Percentage of BrdU+ neuroblasts, 
through expression of the marker, DCX, was calculated and example plots shown from 
Hippocampus (HPC), Hippocampus from an animal which did not receive BrdU injection 
(HPC no BrdU), Cortex (CTX), and Subventricular Zone (SVZ).  
 
 
  
88 
 
CHAPTER 4 – Conclusions and Future Directions 
 
Conclusions 
 Within the introduction, I discussed critical roles that molecular pathways utilized 
by the immune system in pathogen defense can also contribute to normal (healthy) CNS 
development. This idea formed the basis for the development and characterization of a 
murine WNND recovery model, in order to study how CNS inflammatory processes during 
WNND may contribute to the cognitive impairments experienced by WNND survivors – 
and specifically to spatial learning and memory, which is well-modeled by murine 
behavioral studies. 
Two pathways have been highlighted in previous chapters of this thesis, the role 
of classical complement and microglia in synaptic maintenance through synaptic pruning, 
and the role of cytokines, especially Interleukin-1 signaling, in regulation of neuronal 
progenitor cell proliferation and fate. And although these pathways clearly represent 
pathways with effects on spatial learning and memory in these contexts, additional genes 
and pathways likely play important roles as well, as is suggested by the several hundred 
altered genes identified in our microarray experiment within chapter 2 (Figure 2.2). 
 In chapter 2 we investigated the role of microglia and classical complement-
mediated synaptic pruning during WNND on cognitive function. Using a novel murine 
model to study memory impairments during recovery from WNND, we showed that mice 
exhibit spatial learning and memory deficits during recovery and robust microglial 
activation during the acute phase that persists for nearly two months post-WNV infection. 
Using electron and confocal microscopy, we demonstrate that these activated microglia 
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phagocytize synapses during the peak of WNV infection, leading to a significant loss of 
synapses in the hippocampus and entorhinal cortex. Using whole transcriptome array 
approaches we identified genes and pathways associated with poor spatial learning, 
including molecules involved in microglial- and complement-mediated phagocytosis of 
synapses. Consistent with these data, we observed upregulation of complement protein 
C1q within neurons and microglia and showed that CA3 synapse elimination is abolished 
in mice deficient in either microglia or complement C3. Moreover, we detected 
significantly reduced numbers of hippocampal CA3 synapses in post-mortem human 
specimens of WNV encephalitis compared with age- and sex-matched controls, 
highlighting the relevancy of our murine model for human infections with WNV.  
This study was the first to show synapse elimination as a pathological feature of 
WNV encephalitis and to delineate mechanisms that underlie synapse elimination. While 
the classical complement pathway may, at first glance, represent an intriguing therapeutic 
target for WNND survivors, this avenue must be examined with caution, as many off-
target effects, such as increased susceptibility to further infections could result. A more 
intriguing therapeutic target would include the identification of a component of this 
pathway specifically expressed by microglia, but absent within the periphery. Even in this 
case, the consequences of altering homeostatic synaptic pruning have not yet been 
studied. 
 In chapter 3 we showed that during the acute phase of viral infection, the 
proliferation, migration, and differentiation fates of neural progenitor cells are altered 
despite not being direct targets of WNV infection. Of interest, mice deficient in IL-1R 
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signaling were resistant to both the altered progenitor cell proliferation as well as spatial 
memory impairments which are observed in wild type WNND recovering mice.  
Of interest, there are documented studies linking alterations in network excitability 
of the hippocampal circuit and resulting feedback from GABAergic interneurons to 
regulation of adult neurogenesis172,173. Furthermore, the specific synapses studied within 
chapter 2 were the axon terminals between the dentate gyrus and CA3 pyramidal 
neurons, some of which are derived from adult-born granule cell neurons of the dentate 
gyrus. The combinatorial effect of synapse loss, identified within chapter 2, and reduced 
neurogenesis, identified within chapter 3, is likely to seriously impact hippocampal spatial 
learning and memory long beyond the initial episode of infection. 
 
Future Directions 
Determine if the classical complement cascade prevents transsynaptic spread of 
neurotropic viruses 
 In Chapter 2, I discussed how in response to WNV infection, the classical 
complement cascade is upregulated, leading to the pruning of synapses by microglia. A 
speculative hypothesis is that this process has evolved as a way for virus-infected 
neurons to be recognized and disconnected from the local neural circuit in order to limit 
both transsynaptic viral spread, as is achieved by rabies virus and herpes simplex virus 
type 1, as well as any aberrant or excitotoxic signaling originating from the infected 
neuron. It would be interesting to test if in the absence of a functional complement 
cascade, for example in mice null for complement C3, if either WNV or a virus known to 
traffic transsynaptically, such as HSV-1 is able to spread more quickly. Though it would 
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be most compelling to show this effect in vivo, perhaps a simpler and easier to quantify 
system to use might include a hippocampal ex vivo slice preparation or with primary 
neurons plated in a campenot chamber in coculture with microglia as has been 
described174. In either setup, viral infection would be done (a GFP reporter particle would 
work best for in vitro studies) within specific neurons of a slice preparation or within one 
side of the campenot chamber, followed by measurements of viral spread to connecting 
neurons either in the presence of complement inhibitors or within microglia and neurons 
from complement deficient mice.  
 
Determine if MHC Class I pathway contributes to disruptions in spatial learning and 
memory during WNV recovery 
 In Chapter 2 we performed a microarray experiment to search for candidate genes 
and pathways involved in spatial learning and memory defects in WNV-infected and 
recovering mice. One gene pathway which was identified in our screen, but have yet to 
follow-up with further experiments, is the MHC Class I pathway. This pathway is famously 
known for its role in the immune response in displaying non-self peptides at the cell 
surface for recognition by lymphocytes52. More recently, the MHC class I pathway has 
been shown to be instrumental in setting up neuronal connections and enhancing 
plasticity within the brain during development55,56. The following genes within the MHCI 
pathway were found to be altered specifically within poor spatial learning and memory 
WNV-infected and recovered mice: TAPBP, PSMB8, H2-DMA, H2-T10, HMHA1. Further 
investigation using transgenic and knockout mice might yield insights into how induction 
of this pathway during CNS infection may impact correlates of learning and memory.  
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Additional gene transcripts altered in WNV-poor learners with known effects on 
neurons and neural connections include, Sema6c and Sema3e175, ROBO1, Sema3F176. 
These molecules represent additional targets which could be further investigated. 
 
Determine if IL-1R antagonism in wild type mice rescues spatial learning and memory 
during WNV recovery  
Since it is known that IL-1R -/- mice exhibit baseline (naïve animals) differences to 
both spatial learning and memory and neurogenesis, a better test to determine the role 
of IL-1R signaling is to do so in the absence of any developmental abnormalities, in wild 
type mice. To do so, IL-1RA (IL-1 receptor antagonist) could be administered peripherally 
(high dose) or via the lateral ventricle. The timing of this administration would have to be 
determined using pilot studies, since our group has previously reported that IL-1R 
signaling is crucial to proper T cell priming and viral clearance10 – thus the therapy should 
probably begin at approximately 12-15 days post-infection, a point in time when virus is 
on the decline and T cells have already received priming. Mice would then be tested on 
the Barnes Maze spatial memory task at days 46-50 post-infection as has been previously 
described. 
 
Determine if the WNV-mediated reduction in neurogenesis is due to direct infection, PRR 
recognition by NPCs, or a more global cytokine effect  
 Two experiments could be performed to address this question. First, the incubation 
of neurosphere-derived neuronal progenitors could be incubated with WNV in vitro, and 
pulsed with BrdU in the media. Rates of division would be measured in the setting of WNV 
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or PBS (control) conditions. The second experiment would involve injecting ultraviolet-
killed WNV intracranially, and measuring rates of neuroblast proliferation as was done 
previously (Chapter 3). If UV-killed WNV induces similar deficits in neurogenesis, this 
would suggest a more global, pattern recognition receptor-mediated induction of 
cytokines which impacts on the process of adult neurogenesis. If UV-killed WNV fails to 
induce an alteration in proliferation, then the experiment is less conclusive and could 
indicate either a certain threshold of infection necessary to elicit the neurogenic 
alterations or that live, replicating virus is necessary for the response. 
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